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ABBREVIATIONS 
18F-FDG PET: fludeoxyglucose 18F - PET 
ACAS: Asymptomatic Carotid Atherosclerosis Study 
AHA: American Heart Association 
CCA: Common Carotid Artery 
CE: Contrast-enhancement  
CEA: Carotid Endarterectomy 
CT: Computed Tomography 
CTA: Computed Tomography Angiography 
CUBE: the GE name of their sequence and not an acronym 
DCE-MRI: Dynamic Contrast Enhancement Magnetic Resonance Imaging 
DIR: Double Inversion Recovery 
DSA: Digital Subtraction Angiography 
ECST: European Carotid Surgery Trial 
FC: Fibrous Cap 
FDA: Food and Drug Administration 
 
FOV: Field-of-View 
FSD: flow-sensitive dephasing 
GBCA: gadolinium-based contrast agents 
 
GRE: Gradient Echo 
HU: Hounsfield Unit 
IMT: Intima-media Thickness 
ICA: Internal Carotid Artery  
IPH: Intra-plaque Hemorrhage 
IT: Inversion time 
IVUS: Intra-vascular Ultrasound  
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keV: kiloelectronvolt 
LRNC:  Lipid-rich Necrotic Core 
MPRAGE: Magnetization Prepared Rapid Acquisition Gradient Echo  
MRA: Magnetic Resonance Angiography 
MRI: Magnetic Resonance Imaging 
MSDE: Motion-sensitized driven-equilibrium 
NASCET: North American Symptomatic Carotid Endarterectomy Trial 
PET: Positron Emission Tomography 
PGLA: Polymer hydroxyl acidic core 
QIR: Quadruple Inversion Recovery 
SNAP: Simultaneous Non-contrast Angiography and intraPlaque Hemorrhage 
SNR: Signal-to-Noise Ratio 
SPACE: Sampling Perfection with Application optimized Contrasts using different flip angle 
Evolution (Siemens) 
TIA: Transitory Ischemic Attack 
TOF: Time-of-Flight 
US: Ultrasound 
USPIO: Ultra-small Super-Paramagnetic Iron Oxide 
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ABSTRACT 
Identification of carotid artery atherosclerosis is conventionally based on measurements of 
luminal stenosis and surface irregularities using in-vivo imaging techniques including ultrasound, 
CT and MR angiography, and digital subtraction angiography. However, histo-pathological studies 
demonstrate considerable differences between plaques with identical degrees of stenosis and 
indicate that certain plaque features are associated with increased risk for ischemic events. The 
ability to look beyond the lumen using highly developed vessel wall imaging methods to identify 
plaque vulnerable to disruption has prompted an active debate as to whether a paradigm shift is 
needed to move away from relying on measurements of luminal stenosis for gauging risk of 
ischemic injury. Further evaluation in randomized clinical trials will help to better define the exact 
role of plaque imaging in clinical decision-making. However, current carotid vessel wall imaging 
techniques can be informative. The goal of this paper is to present the perspective of the ASNR 
Vessel Wall Imaging Study Group as it relates to the current status of arterial wall imaging in 
















The word “atherosclerosis” is derived from the two Greek words “athera” (mush) and 
“sclerosis” (hardening), indicating hardening of the vascular wall. This disease is highly prevalent 
in developed countries with carotid artery narrowing reported in up to 75% of men and 62% of 
women aged 65 years and older1. Stroke is the second most common cause of death worldwide196 
and approximately 18-25% of all strokes are due to carotid atherosclerotic disease197. 
Conventionally, identification of atherosclerosis affecting the carotid artery is based on 
measurements of the degree of luminal stenosis and surface irregularities2,3 by ultrasound, catheter 
based angiography, and nowadays CTA or MRA4,5. However, histo-pathological studies initially 
performed on coronary arteries and subsequently on carotid arteries, demonstrate considerable 
differences between plaques with identical degrees of stenosis. These observations led to research 
indicating that certain plaque features are associated with increased risk for ischemic events6,7,8. The 
more recent introduction of fast multi-detector row Computed Tomography (CT) technology, high 
field MRI, and advanced ultrasound (US) systems has enabled accurate characterization of plaque 
features that relate to risk of ischemic injury9,10,11,12. The ability to look beyond the lumen using 
advanced wall imaging methods to identify “vulnerable plaque”13,14 is spurring a paradigm shift 
away from simple measurement of percent luminal stenosis for gauging risk of ischemic injury. 
Currently, characterization of the vessel wall and atherosclerotic plaque are the focus of several 
ongoing research studies that are investigating the optimal approach to vulnerable plaque 
imaging18,167,168.  
Further evaluation in randomized clinical trials is needed to establish the exact role of 
plaque imaging in clinical decision-making. However, carotid vessel wall imaging techniques may 
be beneficial at present. For example, improved visualization of the location and extent of 
atherosclerotic plaque would assist in surgical planning prior to endarterectomy or carotid artery 
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stenting. Vessel wall imaging may also be helpful in borderline clinical cases. Identification of 
carotid plaque harboring a large lipid-rich necrotic core (LRNC) plaque with ulceration and intra-
plaque hemorrhage (IPH) despite guideline based medical therapy in a patient with repeated strokes 
and 50% carotid stenosis may lead to consideration for carotid endarterectomy. In asymptomatic 
patients, vessel wall imaging with large LRNC may represent the phenotype of atherosclerotic 
disease amenable to more intensive lipid-lowering therapy211.  Similarly, progressive vulnerable 
plaque features with increasing IPH in asymptomatic carotid stenosis may benefit from more 
intensive lipid-lowering therapy122,212. 
The goal of this paper is therefore to present the perspective of the ASNR Vessel Wall 
Imaging Study Group on the current status of arterial wall imaging in carotid artery disease.  
 
CLINICAL BACKGROUND AND PHYSIOLOGY 
For several years, digital subtraction angiography (DSA) remained the primary imaging 
method for studying carotid arteries for detecting stenosis secondary to atherosclerotic plaque19,20. 
The method provides optimal spatial resolution for defining the opacified lumen, the associated 
degree of luminal stenosis, and plaque-related luminal changes that include lumen irregularity and 
plaque ulcerations21,22.  
Carotid endarterectomy (CEA) trials were undertaken during the 1980s to the mid-1990s 
that quantified the benefit of CEA according to the degree of luminal stenosis2,23,24,25,26.  These 
studies became the basis for considering degree of stenosis as the primary metric for stratifying 
subsequent stroke risk and selecting the optimal therapeutic approach (surgery vs. best medical 
management)23. In particular, three multi-center randomized studies, ECST (European Carotid 
Surgery Trial), NASCET (North American Symptomatic Carotid Endarterectomy Trial) and ACAS 
(Asymptomatic Carotid Atherosclerosis Study) evaluated cut-offs for degree of carotid stenosis as 
they relate to stroke risk reduction by CEA24,25,26.  
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NASCET, ECST and ACAS used DSA to assess the percent reduction in luminal diameter 
of the artery. The methodology for carotid stenosis quantification is debated because NASCET and 
ECST used indirect ratio-percent methods16. Stenosis measurements with NASCET and ECST 
differ substantially: with the ECST method twice as many stenoses were classified as severe and 
less than a third of the number of stenoses as mild compared to the NASCET method 27. Techniques 
that enable identification of both outer and inner walls of the artery might lead to more accurate 
assessment of risk. Bartlett et al28 suggested use of this direct diameter based-measurement to 
overcome the limitations of the percent-based methods and the results they found suggest that this 
technique could be efficient. 
The degree of luminal stenosis as a marker of atherosclerotic disease severity has been 
criticized because of observations that plaques producing only mild to moderate stenosis may still 
lead to acute cerebral infarction15,17,29,30,31,32,64,148. Histopathologic evaluation of these plaques 
showed that plaque erosion and disruption were common morphologic features found in 
symptomatic lesions, indicating that luminal narrowing was not the sole predictor of 
cerebrovascular events 29,30,31. 
These studies introduced the following new concepts: (1) the degree of carotid stenosis is a 
weak indicator of the volume and extension of carotid plaque33,34,35; (2) a set of plaque features, 
identifiable by imaging are closely linked to the development of ischemic symptoms, and (3) these 
features can significantly increase the risk of stroke regardless of the degree of stenosis36,37,38,39 
Thanks to advancements in the imaging techniques to specifically target the vessel wall as opposed 
to the vessel lumen, considerable research effort is underway to identify those plaque-related 
parameters that, together with the degree of stenosis, can more accurately predict the presence of 
vulnerable plaque and the associated risk of ischemic events. 
More than 30 years ago, Imparato et al6 found that there were certain plaque features, such 
as IPH, that were associated with an increased risk of plaque rupture and distal embolization. Since 
that time, roughly 1000 papers have been published on IPH as well as characterizing additional 
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features associated with plaque vulnerability, including the thickness of the fibrous cap, rupture of 
the cap, presence and size of the LRNC, and the presence of active plaque inflammation. 
Vulnerable plaques also tend to be characterized by an eccentric distribution, an irregular surface of 
the intimal layer, or superficial ulcerations with intimal exposure. 
 
- Imaging Features of Plaques at Risk for Stroke 
US can assess plaque composition based on echogenicity with classification systems 
proposed by Geroulakos et al53 and Bluth et al54. The presence of echogenic/hypoechogenic 
elements are associated with the LRNC55,56 whereas hyperechogenic regions or the presence of 
acoustic shadowing is indicative of calcification. US is sensitive in identifying calcification but 
when present, the ensuing acoustic shadowing limits visualization of tissues deep to the 
calcification57.  
CT has been used to type plaques based on Hounsfield attenuation. De Weert et al40,41 
categorized plaques as fatty for attenuation values < 60 HU, mixed for attenuation values between 
60 HU and 130 HU, and calcified for attenuation values > 130 HU. By applying these thresholds, it 
is possible to identify those plaques with a LRNC from others with a prevalent expression of 
myofibroblasts, hemorrhage, or calcification75. Based on this analysis, calcified plaques were found 
to be 21 times less likely to be symptomatic than non-calcified plaques45 whereas fatty plaques were 
clearly associated with an increased risk of rupture39,46,.  
MRI has the ability to distinguish plaque components such as the LRNC, fibrous tissue, and 
IPH with high accuracy47,48,49,50,68,151. The identification of calcified components can be more 
challenging than CT but MR typically offers good results51,52.  
 
- Luminal Morphology and Ulcerations 
The morphology of the luminal surface of carotid plaques can be classified as smooth, 
irregular or ulcerated58. A smooth surface is identified as plain luminal morphology without any 
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sign of ulceration or irregularity. An irregular surface indicates the presence of small alterations of 
the luminal surface on the luminal profile of the plaque; this condition is considered a risk factor for 
embolism and is associated with an increased risk of TIA/stroke49. The third type of morphology is 
the ulceration. Plaque ulceration has been defined as “an intimal defect larger than 1 mm in width, 
exposing the necrotic core of the atheromatous plaque”59; however other authors suggested other 
(smaller) sizes153,154,155. The NASCET study demonstrated a significantly increased risk of 
cerebrovascular events in plaques with ulcerations2.  
 
- Intra-plaque hemorrhage 
IPH is a common feature of atherosclerotic plaques and is considered one of the identifying 
features of vulnerable plaque64. A number of studies have found a statistically significant 
association between the presence of IPH and cerebrovascular events65,192 and IPH has been 
implicated in plaque progression231.  It is thought that the rupture of neovessels or plaque rupture 
itself causes IPH and some conditions such as inflammation, metabolic disease or diabetes may 
precipitate this event67. Recent literature also indicates a potential role of blood pressure66,191.  
 
Fissured Fibrous Cap and Lipid Rich Necrotic Core (LRNC) 
 
 The fibrous cap (FC), which separates LRNC from vessel lumen, is considered one of the most 
important features of the carotid artery vulnerable plaque model.  The FC is a layer of fibrous 
connective tissue and contains macrophages and smooth muscle cells within a collagen-
proteoglycan matrix associated with T-lymphocytes78. Vulnerable plaques are characterized by the 
presence of a thin FC covering a large LRNC containing macrophages and inflammatory cells. In 
both cross-sectional and longitudinal studies38,122, the LRNC size was found to be a strong predictor 
of fibrous cap disruption. The fissuring or rupture of the FC exposes the LRNC to luminal blood 
activating the thromboembolic cascade. Therefore, LRNC and FC status are expected to 
be associated with risk of cerebrovascular events, as shown in single-center experience170,192,193 The 
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intact thick FC is associated with a low risk of plaque rupture, a thin FC is associated with a mild 
risk, while a fissured FC is associated with a high risk of plaque rupture81. Additionally, percent 
LRNC area exceeding 40% of vessel wall area indicates a high risk for plaque rupture while percent 
luminal stenosis did not correlate with plaque rupture 122.  
 
 
- Neovascularization and inflammation 
Intraplaque neovascularization arises from newly formed microvessels that grow into the 
intima through breaks in the medial wall and are characterized by leaky capillaries with an 
endothelial lining that is immature, and imperfect due to the harsh atherosclerotic environment. 
Histopathological studies have demonstrated that neovessels can be found within carotid artery 
plaques, and the degree of neovascularity is associated with the “activity” of the plaque in terms of 
inflammation and increased risk of neovessel rupture and hemorrhage (IPH)87,88. Inflammation of 
unstable “vulnerable” atherosclerotic plaques was first identified in coronary artery lesions and 
subsequently demonstrated in carotid artery plaques102,103.   
The recruitment of inflammatory cells in atherosclerotic lesions is a constitutive 
phenomenon seen throughout the process of lesion initiation and plaque growth. In addition, 
inflammation appears to play a role in the process of plaque disruption104. Inflammatory cells are 
typically found in the plaque shoulder, in the cap, or both103. In many instances and particularly in 
advanced plaques with a complex architecture, inflammatory cells tend to accumulate focally within 
plaques103,104.  
Several types of inflammatory cells are detected in the carotid artery vulnerable plaque and 
some studies have found that the presence of macrophages is significantly associated with the risk 
of plaque rupture105,106,107; therefore, the identification of macrophages has become the target of 
imaging studies devoted to the detection of plaque inflammation108,109,110,111,112.  
 
- Plaque remodeling (positive vs negative) 
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The concept of plaque remodeling was initially described for atherosclerotic lesions in 
coronary arteries but is largely accepted for other vascular beds including the carotid arteries117,118. 
Carotid plaques can show either positive or negative remodeling or both. Positive remodeling is 
dilatation of the vessel wall in response to an increase in plaque volume with little or no 
compromise of the vessel lumen as the vessel initially attempts to maintain normal lumen 
diameter119. Negative remodeling is present when the vessel lumen diameter is decreased (stenosis). 
 
- Plaque Volume 
Recent studies have demonstrated that the volume of the carotid artery plaque could play a 
role in determining plaque “vulnerability” and risk of cardiovascular events161. Increasing plaque 
volume predicted cardiovascular events163. Some authors have hypothesized that the plaque volume 
may be a better indicator of the severity of atherosclerotic disease than the degree of stenosis122. 
Non-invasive in vivo assessment of atherosclerotic plaque volume and the relative contribution of 
different plaque components clearly have important clinical implications as they relate to risk 
assessment for ischemic events. In addition, it has been shown that higher LRNC volumes appear to 
be associated with the presence of plaque ulcerations, representing a significant risk factor for the 
development of cerebrovascular events125. Furthermore, plaque composition is known to change 
with increasing plaque volume. More specifically, there is an increase in the proportion of lipid and 
calcification with increasing plaque volume125. Plaque length, which relates more directly with 
plaque volume than degree of stenosis, has been shown to be an independent risk factor for peri-





- Summary concepts 
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It is clear that there are several plaque features of increased clinical risk supported by 
associations with endarterectomy specimen analyses. It is of utmost importance to test management 
strategies based on these MRI-defined features of risk before treatment guidelines can be 
established.. Currently there are several prospective trials intended to examine the value of 
prospective plaque imaging (ARIC, PARISK, CAPIAS, CARE-II, CAIN)152,202,203,204,205,208. In the 
meantime, it is possible that carotid plaque characterization may be of immediate clinical value 
today. Given that the presence of IPH, large LRNC, and/or thin-ruptured FC are associated with a 
higher risk of future cardiovascular events, the presence of these plaque features may warrant closer 
clinical follow-up and consideration for more intensive medical therapy.  Despite attempts to 
encourage all physicians to manage atherosclerosis medically with current evidence-based 
guidelines, many patients are not receiving high intensity lipid lowering therapy even when 
indicated.  Providing additional information based on carotid plaque MRI identification of IPH, 
large LRNC, and/or thin-ruptured FC may improve patient/physician compliance with current 
therapeutic guideline. If patients receiving standard-of-care medical therapy have repeated strokes 
ipsilateral to carotid plaque harboring “vulnerable” plaque features, they may warrant surgical 
intervention even if they do not meet the stenosis thresholds by NASCET criteria. 
 
CURRENT IMAGING STATE-OF-THE-ART 
In this section of the paper we will summarize the imaging techniques that can be used in the 
imaging of the carotid artery wall. 
 
- US 
US is generally accepted as the standard imaging modality for first-line diagnosis of 
atherosclerosis of the carotid artery126. US has shown very good results in the identification and 
characterization of high-risk plaques in patients with atherosclerosis127. In particular, the use of 
micro-bubble contrast material facilitates assessment of vulnerable plaque features such as the 
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presence\absence of neovascularization97,98. The recently introduced volumetric US technology 
seems to add further value to this technique by improving the inter-observer concordance and 
increasing the spatial coverage128. Another US technique that could be used for carotid plaque 
characterization is intra-vascular US (IVUS). The advantage of IVUS is excellent spatial resolution 
which is possible given the short distance between the probe and the carotid plaque that permits the 
use of high frequency (up to 50 MHz) insonation without excessive attenuation. 
US, however, suffers from some key limitations. In patients with short muscular necks, it 
may be very difficult to identify the carotid bifurcation129. In obese patients or in patients that have 
had radiotherapy, US assessment of the carotid arteries can be challenging. Another limitation of 
US is the evaluation of highly calcified plaques that create acoustic shadowing that can reduce 
visualization of the lesion130. Furthermore, US is less capable of detecting additional, more distally 
located (“tandem”) stenoses than CTA or MRA. It is important to underline that IVUS is invasive 
and is only performed in selected cases that are largely treated with carotid artery stenting and thus 
no pathologic correlate is available. IVUS identification of the fibrous cap or visualization of friable 
plaque may correlate with increased risk of emboli. Moreover, the small cohorts of assessed IVUS 
patients, as well as the potential risk related to the procedure, need further analysis before it is 
included in the routine clinical work-up158. 
Luminal morphology and ulcerations: It has recently been shown that 3D US could be 
effective in the detection of ulceration in carotid artery plaques164,165.  
Intra-plaque hemorrhage: A few papers have assessed US performance in the detection of 
IPH and the results demonstrated low sensitivity and specificity76,77.  
Fibrous cap status: Some authors have explored the potential of conventional US to 
characterize FC but the results obtained were sub-optimal198,199,200. Recent papers156,157 have 
suggested that intra-vascular ultrasonography (IVUS) can assess in detail plaque structure and FC 
but with associated procedural risk.  
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Neovascularization and inflammation: several recently published95,96,97,98 contrast-
enhanced ultrasound studies found that sonographic enhancement correlates with intraplaque 
neovascularization in carotid endarterectomy specimens. However, the reproducibility and utility of 
this modality for clinical care are not well established99. 
It is important to underline that US can also be used to assess those initial subtle wall 
alterations in the very early phases of atherosclerosis progression, for example, the intima-media 
thickness (IMT), that is considered a significant predictor of coronary and cerebrovascular 
events131,132.  
Recent studies assessed the reliability of US for assessing certain plaque features. Bar et 
al189 assessed plaques in 30 patients. Inter-rater agreement values for the following plaque features 
were as follows: homogeneity 96% (κ = 0.84; P < .001), surface characteristics 90% (κ = 0.77; P < 
.001), and echogenicity 86% (κ = 0.60; P < .001). The correlation coefficient for plaque content and 
volume measurement agreement was 0.81 and measurements did not differ significantly (P=n.s.). In 
a paper published in 1999 by Hartmann190 the kappa values and 95% confidence intervals for inter-
rater reproducibility were 0.05 (-0.07 to 0.16) for plaque surface structure, 0.15 (0.02 to 0.28) for 
plaque heterogeneity, 0.18 (0.09 to 0.29) for plaque echogenicity, and 0.29 (0.19 to 0.39) for plaque 
calcification. The upper bounds of all of the confidence intervals were below the 0.40 level 




Modern CT scanners can provide exquisite, rapid high resolution imaging of the carotid 
artery lumen and the arterial wall. The introduction of multi-energy technology provided a 
tremendous boost to the development of CT techniques and constant advances in detector 
technology, in spatial and temporal resolution and release of advanced software for image 
reconstruction have helped to consolidate this technique as a reliable tool for the evaluation of 
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arterial pathology, with particular success in the detection and characterization of carotid 
atherosclerosis.  
Because of its spatial resolution CT imaging seems to be a promising tool for the 
quantification of the volume of the carotid plaque as well as for the volume quantification of plaque 
sub-components (fatty – mixed – calcified) (Figure 1). Moreover, the introduction of multi-energy 
technology is opening new options in tissue characterization because the different tissue 
components show different attenuation levels with varying keV values42. 
Luminal morphology and ulcerations: CT offers very good results in detecting ulcerations 
when compared to histopathology (Figure 2), with performance significantly better than US60,61, 
but the presence of a halo or edge blur may hinder detection of smaller ulcerations.  
Intra-plaque hemorrhage: Detection of IPH using CT is challenging and conflicting 
results have been reported. While some authors have found that CT density is slightly higher in fatty 
plaques with IPH identified by MRI compared to plaques without IPH201, others found no 
significant differences in HU of fatty plaques with and without IPH identified by MRI202. Other 
authors found a correlation between the presence of IPH and low HU value (< 30 HU)74,75 which 
might be explained by the associated presence of LRNC. Recently, some authors suggested that the 
rim sign on CTA (soft tissue plaque with adventitial calcifications) as well as maximum soft plaque 
thickness could be predictive of carotid IPH214. 
Fibrous cap status: The assessment of the status of the FC using CT is complex because of 
the artifacts related to the edge-blur and halo effects, but authors suggest that CT can be used to 
assess the FC status, in particular to identify rupture85,86. Notably, it seems that the rupture of the 
FC correlates with the presence of post-contrast plaque enhancement in CTA analysis36.  
Neovascularization and inflammation: The degree of post-contrast plaque enhancement 
has been shown to be associated with the extent of neovascularization on CT43. The adventitial 
neovascularization has been assessed with both MR159 and CT91,92. Romero et al. showed adventitial 
neovascularity on CTA to be significantly more common in symptomatic than in asymptomatic 
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patients with ≥70% stenosis91 and for stenosis between 50% and 70%92 and similar findings have 
been reported by MRI159. 
Plaque remodeling: CT studies have found that positive carotid remodeling was 
significantly greater in patients with cerebral ischemic symptoms than in asymptomatic patients and 
that the extent of expansive remodeling may indicate underlying atherosclerotic plaque 
vulnerability120,121.  
Plaque volume: CT can calculate the volume of the carotid artery plaque and determine the 
volume of the sub-components, according to HU threshold123. Further it has been shown in a 
CT/MRI comparison study that the best discriminating factor for predicting a complicated AHA 
type VI plaque is the thickness of the fatty plaque component with a receiver operating 
characteristic area under the curve of 0.89202.  
CT limitations: CT imaging has 3 main limitations: 1) the radiation dose delivered to 
patients, 2) the risk related to the administration of contrast material, and 3) the limited fatty tissue 
contrast. Diagnostic radiation exposure and the consequent potential radiation hazards represent a 
significant issue 133,134 particularly when longitudinal monitoring is required.  The second limiting 
factor of CT is the potential anaphylactic reaction to contrast material136,137 and contrast-induced 
nephropathy that is a common form of hospital-acquired acute renal failure138,139. A further 
limitation of CT is the limited published information concerning reliability of this technique and the 
prospective value of CT-based plaque features on stroke risk and / or stroke recurrence. 
 
- MR 
The use of high field strength (1.5 - 3 T) and dedicated surface radiofrequency coils improve 
the signal-to-noise ratio that allows for the evaluation of plaque components and investigation 
beyond the simple assessment of stenosis measurements. Multi-contrast carotid MRI (including T1-
W, T2-W, and PD and TOF) can characterize plaque components (e.g., fibrous cap, LRNC, 
calcification, and intraplaque hemorrhage) without administration of contrast agents.  Contrast-
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enhanced MRI improves tissue characterization48,49 and offers information on the presence of 
neovascularization (Figure 3, Figure 4).  
Luminal morphology and ulcerations: MRI detects plaque ulcerations with sensitivity 
similar to CT63 (Figure 2). Etesami et al63 demonstrated that the use of contrast-enhanced MRA 
techniques improved the sensitivity for ulcerations by 37.5% compared to an unenhanced Time-of-
Flight sequence. 
Intra-plaque hemorrhage: MRI is considered the best imaging technique for the detection 
of IPH (Figure 3, Figure 5). Several studies have shown that the appearance of IPH depends on the 
oxidative state of the hemoglobin69,70,71. Because of the sensitivity of MRI in detecting IPH and the 
risk attributed to this feature, some authors suggest that MRI is the best modality for imaging 
carotid artery vulnerable plaque10,64,68,72,73. During the subacute and chronic phases, IPH appears 
bright on T1-weigthed imaging due to the relatively short T1 of methemoglobin. This phenomenon 
has been exploited using widely available sequences such as MP-RAGE, though other heavily T1-
weighted techniques have been developed to satisfy this purpose such as MATCH and SNAP 
(Figure 6, 7). In MATCH, hyper-T1 contrast weighting is achieved by using inversion preparation 
and data acquisition at the background nulling point, and thus IPH can be exclusively visualized 
with a near dark background; on the other hand, background tissues can readily be visualized on 
other contrast weightings, thanks to the inherently co-registered multi-contrast acquisition181,182 
(Figure 7). IPH detection using 3D SNAP enables greater conspicuity of the lumen boundary 
compared to MP-RAGE179 (Figure 5, 6, 7). SNAP provides the advantage of 3D isotropic 
resolution, as well as simultaneous bright-blood angiography to detect stenosis or ulceration that 
may be co-localized with IPH230.  It is worth noting that it is not necessary to restrict carotid wall 
imaging to dedicated, small field-of-view (FOV) surface coils for IPH detection since this can be 
achieved at lower spatial resolution using large FOV neck coils68,170,213 (Figure 3).  In fact, IPH 
detection can be achieved on the mask sequence acquired as part of a routine contrast-enhanced 
MRA68 (Figure 3). 
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Lipid-rich necrotic core:  Initial research demonstrated that LRNC could be detected as a 
focal hypointense region on T2-W images177,178 (Figure 8).  Multiple studies have confirmed the 
improved detection of LRNC seen as a focal non-enhancing region on contrast-enhanced T1-W 
images within the carotid vessel wall48,49.  Larger LRNC size correlates with future ipsilateral 
carotid symptoms.  All validation of LRNC detection/quantification and predictive features has 
been based on multi-contrast carotid plaque MRI protocol using dedicated carotid coils.  Recent 
work has suggested the ability to detect large LRNC using commercially available 3D T1-W 
sequences and large FOV neck coils.  The Canadian Atherosclerosis Imaging Network (CAIN) has 
recently completed a prospective, multi-institution study using large FOV neck coils and 
commercial sequences from a variety of MR vendors to detect LRNC and IPH. When fully 
analyzed, CAIN may give us additional information about the ability of IPH and LRNC size 
detected with large FOV neck coils and commercial sequences to predict future ipsilateral events. 
Fibrous cap status: MRI can assess fibrous cap status49,82, as opposed to the other non-
invasive imaging modalities such as CT and US85. A regular (thick) FC is characterized by the 
presence of a juxtaluminal band of low signal on time-of-flight (TOF) MR images and / or a 
hyperintense juxtaluminal region on contrast enhanced T1w images whereas a thin FC is present 
when this band of low signal on TOF or the hyperintense region on CE-T1w is not visible or when 
the juxtaluminal hyperintense region on CE-T1w MRI is interrupted. The fissured fibrous cap is 
characterized by two distinct features: 1) the absence of the juxtaluminal band of low signal and 2) 
the presence of a bright gray region adjacent to the lumen, corresponding to plaque hemorrhage 
and/or mural thrombus83,84.  As shown by Wasserman et al and Cai JM et al 48,49,, contrast enhanced 
imaging could be useful for improving delineation of the cap compared to non-contrast (T2), and 
CE T1w imaging can be used to quantify the fibrous cap and the LRNC. Although resolving a thin 
fibrous cap defined by pathologic criteria would necessitate a higher field strength to overcome 
signal constraints, distinguishing thin/ruptured from thick fibrous cap thicknesses can be achieved 
at 1.5T (Figure 8)90,232.    
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Consistent visualization of the FC requires dedicated carotid surface coils. Yuan C et al84 
and others have shown that the fissured FC has a statistically significant association with the 
presence of cerebrovascular symptoms81 and is associated with a higher risk of ischemic symptoms 
in prospective studies170,193. 
Neovascularization and inflammation: There are new contrast agents using iron particles 
(ultrasmall super-paramagnetic iron oxide (USPIO) or P947)149,150 that can evaluate plaque 
inflammation via uptake by phagocytic cells within the inflamed vessel wall. Small particle-based 
MRI contrast agents (iron oxide) can be used to evaluate the presence of plaque inflammation. 
These iron oxide particles enter atherosclerotic plaques with the agents accumulating in 
macrophages transformed from blood monocytes attracted by inflammatory mediators108. High-risk 
inflamed plaques contain a focal area of signal loss on MR images, due to iron oxide 
accumulation109. Iron nanoparticles (10–300 nm-sized) are also bound to antibodies, drugs, 
peptides, polysaccharides, and avidin–biotin cross-linked with polymers are used to assess 
endothelial function in animal models.  Polymer hydroxyl acidic core (PGLA, PLA), dendrimers 
[polyamidoamine (PAMAM), diaminobutane (DAB)] have been described as suitable to 
functionalize the surface of superparamagnetic iron oxide145 (15–60 nm SPIO) particles, allowing 
for ligand binding. Ligand-bound SPIO (anti-VCAM-1 and anti-E-selectin antibody conjugated 
SPIO) can cause dephasing and loss of T2* signal intensity due to susceptibility effects and are 
suitable for passive targeted imaging of inflammation in cardiovascular tissue145.  In addition to iron 
oxide nanoparticle, various other nanoparticles are being used for molecular imaging of 
atherosclerosis in animal models e.g. liposome vesicles (50–70 nm) for US141 / MRI142, 
perfluorocarbon core emulsions (200–300 nm) for MRI, US, fluorescence, and nuclear imaging, 
CTI143, HDL, and LDL micelles for MRI144.  Other types of particles such as gold, carbon nanotube 
fullerenes (4 nm), quantum dots cadmium selenide spheres (2–10 nm) and metal-based agents are in 
the process of standardization and may be useful in fluorescent imaging146. Moreover, other 
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investigators have reported the possibility of viral capsid protein cages with gadolinium as potential 
nanospheres for drug encapsulation and imaging147.  
 
A recent MR study93 showed that enhancement of carotid plaque after administration of 
gadolinium is associated with neovascularization (p < 0.001) (Figure 4). The correlation between 
the degree of plaque enhancement and the degree of neovascularization, which is itself linked to the 
degree of plaque inflammation, was also confirmed at histology in a recent study by Millon et al94. 
Investigations have shown that inflammatory cells are also present at the interface with the 
underlying necrotic core and in the plaque shoulder region79,80. From the imaging point of view, it is 
possible to distinguish two different types of neovascularization: 1) adventitial neovascularization 
and 2) intra-plaque neovascularization. The adventitial neovascularization has been assessed with 
MR159. Ectopic neovascularization in the intima and media is a hallmark of advanced 
atherosclerotic lesions but the adventitial layer is a fundamental target because it serves as the main 
source of ingrowth of new vessels. The degree of neovascularity measured using gadolinium 
perfusion methods correlated with adventitial perfusion as measured by its transfer constant89 
(Figure 9). Wasserman et al. categorized the circumferential enhancement (0, absent; 1, <50%; 2, 
≥50%) on post-contrast MR by finding an association between grade of adventitial enhancement 
and cerebrovascular events. Plaque perfusion imaging using DCE-MRI has been shown to give 
reproducible physiological measurements of vasa vasorum194,195. However, protocol compliance 
may be more important for functional imaging such as DCE-MRI as compared to anatomic 
imaging.  
Plaque volume: Recently published studies show the utility of MRI for this type of 
quantification 124,166. In general, the reliability of MRI for plaque assessment has been very good. A 
study published by Wasserman in 2010166 found that scan reliability for CCA lumen area was 0.94 
whereas for ICA lumen area 0.89. In the assessment of the total wall volume the value was 0.79 but 
in the assessment of LRNC volume the value was very low (0.3). The authors found that overall 
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reliability is primarily related to reader variability rather than scan acquisition.  The CV values for 
the plaque area or plaque volume are between 3-6%, as demonstrated by Saam et al187,188. 
Imaging studies have documented changes in atherosclerotic plaque volume and 
composition, and progression of subclinical lesions into rupture-prone plaques215,216,217,218,219. The 
ability to monitor these changes might contribute to our ability to estimate risk and assess 
pharmaceutical treatment efficacy225. For example, changes in plaque structure that correspond with 
a clinical event help to identify that plaque as a culprit lesion, which puts it at a higher risk for 
future stroke15,200,226. Several studies have reported using MRI for longitudinal analysis of carotid 
plaque variations215,216,217 with fewer reports using CTA218,219.  
 
MR limitations: An important limitation to contrast-enhanced MRI evaluation of plaque 
that has recently emerged is the potential for gadolinium toxicity, particularly when longitudinal 
monitoring is required. Recent  studies have reported the accumulation of gadolinium in various 
tissues of patients without renal impairment, including in bone, brain, and kidneys221,222,223, and in 
July 2015 the U.S. Food and Drug Administration (FDA) published a safety announcement that it is 
investigating the risk of brain deposits associated with the repeated use of gadolinium contrast 
agents in MRI224, stating “To reduce the potential for gadolinium accumulation, health care 
professionals should consider limiting GBCA use to clinical circumstances in which the additional 
information provided by the contrast is necessary. Health care professionals are also urged to 
reassess the necessity of repetitive GBCA MRIs in established treatment protocols”.  This risk must 
now be weighed against the potential radiation hazard described earlier that limits longitudinal 
plaque monitoring by CT.  
 
- Advanced algorithms to carotid artery plaque characterization 
With the development of deep learning technology and plaque characterization algorithms 
applied to medical imaging, it is now possible to identify, classify and quantify target features from 
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imaging datasets such as total carotid artery plaque volume and plaque sub-components detection 
(calcium, IPH, lipid core)227,228. Deep learning technology has experienced rapid progress in health 
care over recent years with early reports of implementation in carotid imaging229 raising the 
prospect of routine use in the clinical setting once validated. 
 
 
- Functional – Molecular Imaging 
 “Molecular” imaging techniques have been gaining popularity. The objective of molecular 
imaging is to provide biological insight into the identification and classification of carotid artery 
plaques especially those at high risk. In atherosclerotic plaques, multiple and complex reactions 
take place at the molecular and cellular level, with various atherosclerosis-related biomarkers 
present at different stages of disease progression140. Conventional imaging with US, MR or CT 
cannot identify these components because of limited imaging contrast and therefore several 
methods have been proposed that use external contrast agents targeting these specific biomarkers.  
A wide variety of studies have assessed the diagnostic potential of nuclear medicine 
techniques for imaging and quantifying plaque inflammation, such as by PET using the widely-
available 18F-FDG or newer radiotracers such as 18F-fluorocholine (Figure 10)114,115,116 . Nuclear 
medicine tracer techniques have also shown efficacy in the identification of 
neovascularization100,101.  
Because vulnerable plaques are infiltrated by lymphocytes and macrophages with the latter 
cell population capable of taking up 18F-FDG from the interstitial spaces, 18F-FDG PET can be 
used to directly detect plaque inflammation in various anatomic locations113. In recent years, a 
number of studies have assessed the diagnostic potential of 18F-FDG PET to image and quantify 
plaque inflammation114,115 as well as monitoring the reduction of plaque inflammation resulting 
from statin therapy116 
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RECOMMENDATIONS   
Carotid MRI  
Background: Results from recently published meta-analyses support the hypothesis that 
MRI detection of carotid IPH is associated with increased risk for future primary and recurrent 
ischemic neurological events169,170,171. Furthermore, absence of IPH portends a benign clinical 
course, even amongst patients with symptomatic 50-99% carotid stenosis171. Other plaque features 
associated with increased risk include identification of a large LRNC and a thin or ruptured fibrous 
cap170.  
Goals: (1) To provide general guidelines for carotid MR vessel wall imaging with 
recommended imaging sequences, spatial resolution and coverage. Guideline considerations are that 
the protocol can be applied broadly across a spectrum of clinical scanners and not require 
specialized software or research keys for implementation. (2) To recommend future areas for 
technical development and clinical expansion needs. 
Essential Features for Identification with Carotid Plaque Imaging: Any MRI protocol 
for plaque imaging should be able to identify the following atherosclerotic plaque characteristics: 
1. Stenosis and luminal surface condition (fibrous cap and ulceration).  
2. Presence of intraplaque hemorrhage. 
3. Presence of lipid rich necrotic core.  
4. Plaque burden and distribution. 
Minimum MRI Protocol Requirements for Identification of Essential Plaque Features 
(1.5T and 3T): Recommended minimum sequence requirements are 
- Resolution: In-plane 0.6 mm, through-plane 2 mm. 
- Longitudinal coverage: 3-4 cm centered on the carotid bifurcation. 
- Effective blood suppression for plaque burden visualization sequence. 
The protocol may include any combination of sequences that meet the minimum 
requirements set forth above. The sequences used can be either 2D or 3D or a combination provided 
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that they together meet the minimum sequence requirements above.  Overall scan time can be 
adjusted based on field strength and availability of specialized hardware such as carotid phased 
array coils.  3T scanners are recommended for improved SNR.   
Example Protocols:  Four protocols are presented based on considerations for 2D and 3D 
imaging and the use of Gadolinium contrast agents (Table 1-4).  If patients are able to undergo 
Gadolinium contrast injection, its use is recommended for the detection and quantification of LRNC 
and the delineation of the fibrous cap48,172.  Use of large coverage 3D sequences can detect plaques 
extending beyond the 4 cm coverage centered on the bifurcation and are preferable.  Carotid coils 
are recommended for use with all protocols, although large FOV neck coils can detect IPH. It is 
possible to add a 4 minute 3D MPRAGE sequence to routine clinical carotid MRA protocol.  The 
protocol is similar to Table 1, but with 0.8 mm isotropic resolution using a large FOV neck coil 
instead of 0.6 mm using dedicated carotid surface coils. Focal regions of T1 hyperintensity within 
the carotid plaque that is 1.5x greater than the adjacent sternocleidomastoid muscle can be used to 
identify IPH. 
 
 MSDE173/FSD174 flow suppression is required for 3D SPACE/CUBE/VISTA to ensure 
effective blood suppression to accurately identify plaque lumen boundaries. Good blood 
suppression post-contrast requires the use of MSDE or DIR/QIR175 flow suppression. For DIR, the 
inversion time (TI) can be calculated based on estimated T1 values of blood at 5 minute intervals 
following contrast administration (0.1 mmol/kg) for 1.5T or 3T scanners206.  We recommend a TI of 
250 ms for 3T scanners for a TR triggered at 1RR interval, which generally produces adequate flow 
suppression beginning 5 minutes after injection despite variations in post-injection scan time and 
heart rate, which will affect the T1 blood values.  
  
Discussion 
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Lumen: Quantifying luminal narrowing is a prerequisite, as stenosis severity is the 
cornerstone for treatment decisions in current clinical guidelines. Furthermore, detection of 
ulceration provides prognostic value. Use of TOF MRA for lumen assessment avoids the need for 
IV contrast, and may provide confirmatory evidence of intraplaque hemorrhage and, sometimes 
calcification. Addition or substitution with CE-MRA should be considered for those without 
contraindication for contrast administration. This would also provide an opportunity to perform 
post-contrast enhanced imaging of the vessel wall for direct identification of the LRNC and 
identification/confirmation of fibrous cap status and ulcerations. 
IPH: MRI techniques are available for IPH detection across scanner platforms, and IPH’s 
predictive value for ischemic events has been extensively evaluated, both with and without custom 
carotid coils. In a review performed by Gupta et al170, studies were stratified by those utilizing 
multi-sequence, carotid coil-dependent protocols and those using a single sequence with standard 
large FOV neck coils for IPH detection. Using either technique, IPH was associated with 
significantly increased risk for TIA or stroke (HR (95% CI) 4.40 (2.10-9.23) and 5.04 (2.15-11.85), 
respectively). While IPH can be identified on T1w sequences such as T1w fast spin echo, T1w 
SPACE, TOF etc., a highly T1 weighted sequence such as MPRAGE can provide higher sensitivity 
and specificity for IPH detection176. 
Lipid-rich necrotic core:  T2 weighted imaging can be used to detect the presence of 
LRNC177,178. Direct assessment of LRNC can also be done in patients undergoing contrast 
administration using a post-contrast T1w scan. CE-MRA followed by post-CE vessel wall imaging 
in patients without contraindication will improve detection and quantification of the LRNC and 
delineation of the fibrous cap172.  
Plaque burden and distribution: Knowledge of the location and distribution of plaque 
assists in pre-procedural planning. Time-efficient 3D large coverage black-blood MRI maybe better 
suited for this purpose.  
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Future improvements and needs for MRI 
Technical developments in the following areas are urgently needed:   
a. Improved spatial resolution both in-plane and through-plane to better characterize finer 
structures such as fibrous caps.  
b. More effective blood flow suppression for large spatial coverage imaging acquisition 
and pre- and post-contrast administration. 
c. Dedicated carotid coils that are integrated with head and neck coils for extensive 
coverage. 
d. Improved techniques for identifying the lipid rich necrotic core, especially without the 
need for contrast application.  
e. More effective methods to deal with motion.  
f. A streamlined imaging protocol that is able to identify multiple imaging targets in one or 
two imaging sequences. 
g. Effective image processing tools for efficient quantitative identification of imaging 
targets 
h. Development of training programs for MR specialists on image acquisition and for 
radiologists on vessel wall image interpretation. 
i. Ultimately – a guideline that clearly calls for the need of carotid plaque imaging and one 
simple protocol that can meet all the needs.   
Currently, there are many new techniques being developed for carotid plaque imaging. 3D-
SNAP provides non-contrast enhanced MRA and simultaneous IPH detection179. 3D-SHINE 
provides information about the state of IPH in addition to IPH detection180. IPH can also be 
identified on a pre-contrast mask of CE-MRA if available68. MATCH provides comprehensive 
information regarding plaque composition in a single sequence182. 3D-MERGE183 and 3D-
DASH184 provide large coverage blood suppression for plaque burden measurements. Diffusion-
weighted imaging can detect LRNC without the use of contrast media209. Self-gating has been 
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used to reject data acquired during swallowing motion210. T1 insensitive blood suppression 
techniques such as Quadruple Inversion Recovery175 provide good blood suppression for post-
contrast imaging. However, these supplementary techniques require specialized equipment (3T, 





Carotid CT  
Background: Currently no meta-analysis or prospective trials have suggested that some 
specific CT features are associated with an increased risk for future primary and recurrent ischemic 
neurological events, even if there are several prospective trials on their way or have been published 
that examine the value of plaque imaging prospectively (PARISK, CAPIAS, CARE-II)202,203,204 
However, cross-sectional studies have found that some CT characteristics (HU attenuation – 
presence of neovascularization) are associated with increased risk of cerebrovascular events39,186. 
Goals: (1) To provide general guidelines for carotid CT vessel wall imaging with 
recommended desirable imaging techniques, tissue contrast, spatial resolution and coverage. 
Guideline considerations are that the protocol can be applied broadly across a spectrum of clinical 
CT scanners and not require specialized software or research keys for implementation. (2) To 
recommend future areas for technical development and clinical expansion needs. 
Essential Features for Identification with Carotid Plaque Imaging: Any CT protocol for 
plaque imaging should be able to identify the following atherosclerotic plaque characteristics: 
1. Stenosis and luminal surface condition (plaque morphology and ulceration).  
2. Type of plaque (fatty versus mixed versus calcified) 
3. Presence of plaque enhancement 
4. Plaque burden and distribution. 
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Minimum CT Protocol Requirements for Identification of Essential Plaque Features: 
Recommended minimum parameter requirements are 
- Resolution: isotropic voxel with 1 mm resolution  
- Longitudinal coverage: from aortic arch to intra-cranial vessel 
- CT generation: third with at least 16-dectetor-row 
Example Protocols:  Four protocols are presented (Table 5-8). No CT study of carotid 
arteries must be performed without the administration of contrast material. The use of biphasic 
approach (un-enhanced scan followed by contrast scan) allows the assessment of the carotid plaque 
neovascularization. This is becoming more important but is not considered currently necessary. In 
order to reduce the radiation dose delivered to the patients the z-length of the basal scan should 
cover only the carotid artery plaque bifurcation (4 cm coverage centered on the bifurcation). Dual 
energy CT technique43 allows virtual un-enhanced image in order to assess plaque enhancement 
without the need of a biphasic approach.    
  
Discussion 
Lumen: Quantifying luminal narrowing is a prerequisite. In order to correctly assess the 
degree of stenosis, by avoiding the halo or edge blur the correct window settings should be used185. 
At the current level of technology, the status of the FC cannot be adequately explored by CT. 
Type of Plaque: According to the HU attenuation the carotid plaque can be categorized as 
fatty (< 60 HU), mixed (between 60 HU and 130 HU) and calcified (> 130 HU). By applying these 
thresholds, it is possible to identify those plaques with a LRNC from others. Applying the HU 
classification, however, creates 2 problems that have recently come to light: (1) the HU value of the 
plaque is dependent on the level of energy applied, as demonstrated by Saba et al by using multi-
energy systems42, (2) the carotid artery plaques may show contrast enhancement (by comparing the 
attenuation values of the basal and post-contrast scans) suggesting that the attenuation value of the 
plaque obtained after administration of contrast material represents two different parameters: the 
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type of the plaque and the degree of neovascularization of the tissue43,44. This is not a problem if pre 
and post contrast scans or dual energy is applied (capable of distinguishing plaque from contrast 
enhancement) but this is not usually done clinically secondary to an increase in x-ray dose 
Carotid plaque enhancement. Assessment of plaque enhancement is limited in the case of 
single phase CTA, and multiphase CTA is rarely performed outside of research studies due to 
radiation concerns. An un-enhanced axial CT obtained over 4 cm centered on the carotid 
bifurcation, followed by a CTA would theoretically be ideal in assessing plaque enhancement but 
carries less radiation penalty.  Alternatively, some authors have employed dual energy techniques 
with use of the virtual non -enhanced image in order to assess plaque enhancement with less 
radiation dose43. 
Plaque burden and distribution: Knowledge of the location and distribution of plaque 
assists in pre-procedural planning. Moreover, CT can calculate the volume of the carotid artery 
plaque and determine the volume of the sub-components, according to HU threshold123.  
 
Future improvements and needs for CT 
Technical developments in the following areas are urgently needed:   
a. Improved contrast resolution for greater discrimination of tissue types in plaque 
b. Improved techniques, such as multi-energy applications for identifying the lipid rich 
necrotic core, especially without the need for contrast application  
c. Evidence based guidelines that invoke the need for carotid plaque imaging preferably 
using one simple universal protocol that can meet all needs.   
Currently, most of the research on carotid artery CT is focusing on methods (1) that reduce the 
radiation dose delivered to the patients, and (2) improve carotid artery plaque characterization 
using multi-energy tools that promise more accurate detection of plaque components. 
 
CONCLUSION 
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In the last 20 years there has been a paradigm shift in the imaging of atherosclerotic carotid 
artery, from the assessment of the degree of luminal stenosis to the characterization of plaque. 
Several features have been identified which are potentially associated with plaque rupture and 
imaging has been used to identify these features in vivo.  
Researchers and clinicians now have several imaging modalities that allow in-depth 
exploration of carotid artery plaque and its components. Sonography should be considered as a first-
line exam, at least for screening, whereas CT and MR improve identification of several plaque 
features associated with vulnerability. 
Also promising are nuclear medicine and molecular imaging techniques that can further 
explore assessment of plaque vulnerability especially inflammation, but these approaches are still 
investigational and not part of the main diagnostic algorithm of carotid atherosclerosis. In the future 
larger prospective longitudinal studies investigating these technological advances may fully exploit 














  31 
ACKNOWLEDGMENT 
The authors would like to thank Drs. Stefan Vöö, Wei Zu, and Zhaoyang Fan for their help in image 























  32 
REFERENCES 
1) Yanez ND, Burke GL, Manolio T, Gardin JM, Polak J; CHS Collaborative Research Group. Sibling 
history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly: the 
Cardiovascular Health Study. Ann Epidemiol. 2009 Dec;19(12):858-66. 
 
2) Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN,  Clagett GP, 
Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD. Benefit of carotid endarterectomy in 
patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid 
Endarterectomy Trial Collaborators.  N Engl J Med. 1998 Nov 12;339(20):1415-25 
 
3) Howarth JC, Klotz JG. The diagnostic value of carotid arteriography; a preliminary report. Cleve Clin Q. 
1951 Jul;18(3):179-83. 
 
4) von Arbin M, Britton M, de Faire U, Gustafsson P. Non invasive assessment of the internal carotid artery 
in stroke patients. Scand J Clin Lab Invest. 1983 Jun;43(4):275-83. 
 
5) Weinberger J. Clinical applications of noninvasive carotid artery testing. J Am Coll Cardiol. 1985 
Jan;5(1):137-48. 
 
6) Imparato AM, Riles TS, Gorstein F. The carotid bifurcation plaque: pathologic findings associated with 
cerebral ischemia. Stroke. 1979;10(3):238-45. Epub 1979/05/01. PubMed PMID: 462508. 
 
7) Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid 
plaques in relation to the nature and timing of ischemic symptoms: The Oxford plaque study. Circulation. 
2006;113(19):2320-8. PubMed PMID: 16651471. 
 
8) Jeziorska M, Woolley DE. Local neovascularization and cellular composition within vulnerable regions of 
atherosclerotic plaques of human carotid arteries. J Pathol. 1999 Jun;188(2):189-96. 
 
9) Choi CJ, Kramer CM. MR imaging of atherosclerotic plaque. Radiol Clin North Am. 2002 Jul;40(4):887-
98 
 
10) Moody AR. Magnetic resonance direct thrombus imaging. J Thromb Haemost. 2003 Jul;1(7):1403-9 
 
11) Oliver TB, Lammie GA, Wright AR, Wardlaw J, Patel SG, Peek R, Ruckley CV, Collie DA. 
Atherosclerotic plaque at the carotid bifurcation: CT angiographic appearance with histopathologic 
correlation. AJNR Am J Neuroradiol. 1999 May;20(5):897-901. 
 
12) Bluth EI. Evaluation and characterization of carotid plaque. Semin Ultrasound  CT MR. 1997 
Feb;18(1):57-65 
 
13) Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, 
Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, 
Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro 
JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori 
SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne  C, Insull W Jr, 
Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, 
Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a 
call for new definitions and risk assessment strategies: Part II. Circulation. 2003 Oct 14;108(15):1772-8.  
 
14) Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, 
Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, 
Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, 
Chesebro JH, Farb A, Galis  ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab 
  33 
M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull 
W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller 
JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: 
a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 7;108(14):1664-72.  
 
15) Wasserman BA, Wityk RJ, Trout HH, Virmani R. Looking beyond the lumen with MRI. Stroke 2005; 
36:2504-2513 
 
16) Bladin CF, Alexandrov AV, Murphy J, Maggisano R, Norris JW. Carotid Stenosis Index. A new method 
of measuring internal carotid artery stenosis. Stroke. 1995 Feb;26(2):230-4. 
 
17) Astor BC, Sharrett AR, Coresh J, Chambless LE, Wasserman BA. Remodeling of carotid arteries 
detected with MR imaging: atherosclerosis risk in communities carotid MRI study. Radiology. 2010 
Sep;256(3):879-86.  
 
18) Zavodni AE, Wasserman BA, McClelland RL, Gomes AS, Folsom AR, Polak JF, Lima JA, Bluemke 
DA. Carotid Artery Plaque Morphology and Composition in Relation to Incident Cardiovascular Events: The 
Multi-Ethnic Study of Atherosclerosis (MESA). Radiology. 2014 Feb 26:131020. [Epub ahead of print] 
PubMed PMID: 24592924 
 
19) Croft RJ, Ellam LD, Harrison MJ. Accuracy of carotid angiography in the assessment of atheroma of the 
internal carotid artery. Lancet. 1980 May 10;1:997-1000. 
 
20) Wardlaw JM, Chappell FM, Best JJ, Wartolowska K, Berry E; NHS Research and Development Health 
Technology Assessment Carotid Stenosis Imaging Group. Non-invasive imaging compared with intra-
arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet. 2006 May 
6;367:1503-12. 
 
21) Liapis CD, Paraskevas KI. Do carotid surface irregularities correlate with the development of 
cerebrovascular symptoms ? An analysis of the supporting studies, the opposing studies and the possible 
pathomechanism. Vascular 2006;14:88-92. 
 
22) Comerota AJ, Katz ML, White JV, Grosh JD, The preoperative diagnosis of the ulcerated carotid 
atheroma. J Vasc Surg 1990;11:505-510. 
 
23) Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled 
trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107–16 
 
24) European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for 
recently symptomatic carotid stenosis:  final results of the MRC European Carotid Surgery Trial (ECST). 
Lancet. 1998;351: 1379-1387. 
 
25) North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid 
endarterectomy in symptomatic patients high with grade stenosis. N Engl J Med. 1991;325: 445-453. 
 
26) Asymptomatic Carotid Atherosclerosis Group. Endarterectomy for asymptomatic carotid artery stenosis. 
JAMA. 1995;73:1421-1428. 
 
27) Rothwell PM, Gibson RJ, Slattery J, Sellar RJ, Warlow CP. Equivalence of measurements of carotid 
stenosis. A comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists' 
Collaborative Group. Stroke. 1994 Dec;25(12):2435-9. 
 
28) Bartlett ES, Walters TD, Symons SP, Fox AJ. Carotid stenosis index revised with direct CT angiography 
measurement of carotid arteries to quantify carotid stenosis. Stroke 2007;38:286-91. 
 
  34 
29) Lovett JK, Gallagher PJ, Hands LJ, Walton J, Rothwell PM:  Histological correlates of carotid plaque 
surface morphology on lumen contrast imaging. Circulation. 2004;110:2190-7 
 
30) Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, 
Ippoliti A, Holmes DR Jr. Extracranial thrombotically active carotid plaque as a risk factor for ischemic 
stroke. JAMA. 2004 Oct 20;292(15):1845-52. 
 
31) Lovett JK, Gallagher PJ, Rothwell PM:  Reproducibility of histological assessment of carotid plaque:  
implications for studies of carotid imaging. Cerebrovasc Dis. 2004;18:117-23 
 
32) Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of  526 symptomatic 
carotid plaques in relation to the nature and timing of ischemic  symptoms: the Oxford plaque study. 
Circulation. 2006 May 16;113(19):2320-8. 
 
33) Mono ML, Karameshev A, Slotboom J, Remonda L, Galimanis A, Jung S, Findling O, De Marchis GM, 
Luedi R, Kiefer C, Stuker C, Mattle HP, Schroth G, Arnold M, Nedeltchev K, El-Koussy M. Plaque 
characteristics of asymptomatic carotid stenosis and risk of stroke. Cerebrovasc Dis. 2012;34(5-6):343-50.  
 
34) Rozie S, de Weert TT, de Monyè C, Homburg PJ, Tanghe HLJ, Dippel DWJ, van der Lugt A. 
Atherosclerotic plaque volume and composition in symptomatic carotid arteries assessed with multidetector 
CT angiography; relationship with severity of stenosis and cardiovascular risk factors. Eur Radiol 2009; 
19:2294–2301. 
 
35) Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, Tran N, Polissar NL, Neradilek B, Jarvik GP, 
Isaac C, Arden GA, Maravilla KR, Hashimoto B, Hatsukami TS. Predictors of carotid atherosclerotic plaque 
progression as measured by non-invasive magnetic resonance imaging. Atherosclerosis 2007;194:e34–42. 
 
36) Saba L, Tamponi E, Raz E, Lai L, Montisci R, Piga M, Faa G. Correlation between Fissured Fibrous Cap 
and Contrast Enhancement: Preliminary Results with the Use of CTA and Histologic Validation. AJNR Am 
J Neuroradiol. 2014 Apr;35(4):754-9 
 
37) Albuquerque LC, Narvaes LB, Maciel AA, Staub H, Friedrich M, Hoefel Filho JR, Marques MB, Rohde 
LE. Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein 
in carotid atherosclerosis. J Vasc Surg.  2007; 46: 1130–1137. 
 
38) Ota H, Yu W, Underhill HR, Oikawa M, Dong L, Zhao X, Polissar NL, Neradilek B, Gao T, Zhang Z, 
Yan Z, Guo M, Zhang Z, Hatsukami TS, Yuan C. Hemorrhage and large lipid-rich necrotic cores are 
independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler Thromb 
Vasc Biol. 2009 Oct;29(10):1696-701. 
 
39) Saba L, Montisci R, Sanfilippo R, Mallarini G. Multidetector row CT of the brain and carotid artery: a 
correlative analysis. Clin Radiol. 2009 Aug;64:767-78. 
 
40)  de Weert TT, Ouhlous M, Zondervan PE, Hendriks JM, Dippel DW, van Sambeek MR,  van der Lugt A. 
In vitro characterization of atherosclerotic carotid plaque with  multidetector computed tomography and 
histopathological correlation. Eur Radiol.  2005 Sep;15(9):1906-14.  
 
41) de Weert TT, Ouhlous M, Meijering E, Zondervan PE, Hendriks JM, van Sambeek MR, Dippel DW, van 
der Lugt A. In vivo characterization and quantification of atherosclerotic carotid plaque components with 
multidetector computed tomography  and histopathological correlation. Arterioscler Thromb Vasc Biol. 2006 
Oct;26(10):2366-72.  
 
42) Saba L, Argiolas GM, Siotto P, Piga M. Carotid artery plaque characterization using CT multienergy 
imaging. AJNR Am J Neuroradiol. 2013 Apr;34(4):855-9. 
 
  35 
43)  Saba L, Lai ML, Montisci R, Tamponi E, Sanfilippo R, Faa G, Piga M. Association between carotid 
plaque enhancement shown by multidetector CT angiography and histologically validated microvessel 
density. Eur Radiol. 2012 Oct;22(10):2237-45.  
 
44) Saba L, Piga M, Raz E, Farina D, Montisci R. Carotid artery plaque classification: does contrast 
enhancement play a significant role? AJNR Am J Neuroradiol. 2012 Oct;33(9):1814-7. doi: 
10.3174/ajnr.A3073. Epub 2012 May 3. PubMed PMID: 22555579.  
 
45) Nandalur KR, Hardie AD, Raghavan P, Schipper MJ, Baskurt E, Kramer CM. Composition of the stable 
carotid plaque: insights from a multidetector computed  tomography study of plaque volume. Stroke. 2007 
Mar;38(3):935-40.  
 
46) Nandalur KR, Baskurt E, Hagspiel KD, Phillips CD, Kramer CM. Calcified carotid atherosclerotic 
plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J 
Roentgenol. 2005 Jan;184(1):295-8. 
 
47) Saam T, Ferguson MS, Yarnykh VL, Takaya N, Xu D, Polissar NL, Hatsukami TS, Yuan C. Quantitative 
evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005 
Jan;25(1):234-9.  
 
48) Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B, Takaya N, Polissar NL, Yuan C. In 
vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid 
plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. 
Circulation. 2005 Nov 29;112(22):3437-44.  
 
49) Wasserman BA, Smith WI, Trout HH 3rd, Cannon RO 3rd, Balaban RS, Arai AE. Carotid artery 
atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR 
imaging initial results. Radiology. 2002 May;223(2):566-73.  
 
50) Wasserman BA, Haacke EM, Li D. Carotid plaque formation and its evaluation with angiography, 
ultrasound, and MR angiography. J Magn Reson Imaging. 1994 Jul-Aug;4(4):515-27. 
 
51) Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid 
atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002 Sep 
10;106(11):1368-73.  
 
52) Hofman JM, Branderhorst WJ, ten Eikelder HM, Cappendijk VC, Heeneman S, Kooi ME, Hilbers PA, 
ter Haar Romeny BM. Quantification of atherosclerotic plaque components using in vivo MRI and 
supervised classifiers. Magn Reson Med. 2006 Apr;55(4):790-9.  
 
53) Geroulakos G, Ramaswani G, Nicolaides A. Characterization of symptomatic and asymptomatic carotid 
plaques using high resolution real time ultrasound. Br J Surg 1993;80:1274-7. 
 
54) Bluth EI, Kay D, Merritt CRB, et al. Sonographic characterization of carotid plaque. AJR Am J 
Roentgenol 1986;146:1061–1065. 
 
55) Grønholdt ML, Wiebe BM, Laursen H, Nielsen TG, Schroeder TV, Sillesen H. Lipid-rich carotid artery 
plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque 
haemorrhage. Eur J Vasc Endovasc Surg.1997 Dec;14(6):439-45. 
 
56) Noritomi T, Sigel B, Swami V, Justin J, Gahtan V, Chen X, Feleppa EJ, Roberts AB, Shirouzu K. 
Carotid plaque typing by multiple-parameter ultrasonic tissue characterization. Ultrasound Med Biol. 
1997;23(5):643-50.  
 
57) Schminke U, Motsch L, Hilker L, Kessler C. Three-dimensional ultrasound observation of carotid artery 
plaque ulceration. Stroke. 2000 Jul;31(7):1651-5 
  36 
 
58) Saba L, Anzidei M, Marincola BC, Piga M, Raz E, Bassareo PP, Napoli A, Mannelli L, Catalano C, 
Wintermark M. Imaging of the Carotid Artery Vulnerable Plaque. Cardiovasc Intervent Radiol. 2013 Aug 3. 
[Epub ahead of print] PubMed PMID: 23912494. 
 
59) Sitzer M, Muller W, Siebler M, Hort W, Kniemeyer H-W, Jancke L, Steinmetz H. Plaque ulceration and 
lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. 
Stroke 1995; 26: 1231-1233 
 
60) Saba L, Caddeo G, Sanfilippo R, Montisci R, Mallarini G. CT and ultrasound in the study of ulcerated 
carotid plaque compared with surgical results: potentialities and advantages of multidetector row CT 
angiography. AJNR Am J Neuroradiol. 2007 Jun-Jul;28(6):1061-6. 
 
61) Saba L, Caddeo G, Sanfilippo R, Montisci R, Mallarini G. Efficacy and Sensitivity of axial scans and 
different reconstruction methods in the study of the ulcerated carotid plaque by using multi-detector-row CT 
angiography. Comparison with surgical results. Am J Neuroradiol AJNR 2007;28:716-23. 
 
62) Kuk M, Wannarong T, Beletsky V, Parraga G, Fenster A, Spence JD. Volume of Carotid Artery 
Ulceration as a Predictor of Cardiovascular Events. Stroke. 2014 Apr 8. [Epub ahead of print] PubMed 
PMID: 24713529 
 
63) Etesami M, Hoi Y, Steinman DA, Gujar SK, Nidecker AE, Astor BC, Portanova A, Qiao Y, Abdalla 
WM, Wasserman BA. Comparison of carotid plaque ulcer detection using contrast-enhanced and time-of-
flight MRA techniques. AJNR Am J Neuroradiol. 2013 Jan;34(1):177-84. 
 
64)  Altaf N, Daniels L, Morgan PS, Auer D, MacSweeney ST, Moody AR, Gladman JR. Detection of 
intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate 
carotid stenosis predicts recurrent neurological events. J Vasc Surg. 2008 Feb; 47(2):337-42. 
 
65) Altaf N, MacSweeney ST, Gladman J, Auer DP. Carotid intraplaque hemorrhage predicts recurrent 
symptoms in patients with high-grade carotid stenosis. Stroke. 2007 May;38(5):1633-5. 
 
66) Selwaness M, van den Bouwhuijsen QJ, Verwoert GC, Dehghan A, Mattace-Raso FU, Vernooij M, 
Franco OH, Hofman A, van der Lugt A, Wentzel JJ, Witteman JC. Blood pressure parameters and carotid 
intraplaque hemorrhage as measured by magnetic resonance imaging: The Rotterdam Study. Hypertension. 
2013;61(1):76-81. Epub 2012/12/06. doi: 10.1161/HYPERTENSIONAHA.112.198267. PubMed PMID: 
23213192. 
 
67) Pasterkamp G, van der Steen AF. Intraplaque hemorrhage: an imaging marker for  atherosclerotic plaque 
destabilization? Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):167-8 
 
68) Qiao Y, Etesami M, Malhotra S, Astor BC, Virmani R, Kolodgie FD, Trout HH 3rd, Wasserman BA. 
Identification of intraplaque hemorrhage on MR angiography images:  a comparison of contrast-enhanced 
mask and time-of-flight techniques. AJNR Am J Neuroradiol. 2011 Mar;32(3):454-9. 
 
69) Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human 
atherosclerosis. Circulation. 2006 May 9;113(18):2245-52. 
 
70) Cappendijk VC, Cleutjens KB, Kessels AG, Heeneman S, Schurink GW, Welten RJ, Mess WH, Daemen 
MJ, van Engelshoven JM, Kooi ME. Assessment of human atherosclerotic carotid plaque components with 
multisequence MR imaging: initial experience. Radiology. 2005 Feb;234(2):487-92.  
 
71) Chu B, Kampschulte A, Ferguson MS, Kerwin WS, Yarnykh VL, O'Brien KD, Polissar NL, Hatsukami 
TS, Yuan C. Hemorrhage in the atherosclerotic carotid plaque: a  high-resolution MRI study. Stroke. 2004 
May;35(5):1079-84. 
 
  37 
72) Bitar R, Moody AR, Leung G, Symons S, Crisp S, Butany J, Rowsell C, Kiss A, Nelson A, Maggisano 
R. In vivo 3D high-spatial-resolution MR imaging of intraplaque hemorrhage. Radiology. 2008 
Oct;249(1):259-67 
 
73) Moody AR, Allder S, Lennox G, Gladman J, Fentem P. Direct magnetic resonance imaging of carotid 
artery thrombus in acute stroke. Lancet. 1999 Jan 9;353(9147):122-3.  
 
74) Wintermark M, Jawadi SS, Rapp JH, Tihan T, Tong E, Glidden DV, Abedin S, Schaeffer S, Acevedo-
Bolton G, Boudignon B, Orwoll B, Pan X, Saloner D. High-resolution CT imaging of carotid artery 
atherosclerotic plaques. AJNR Am J Neuroradiol. 2008 May;29(5):875-82.  
 
75) Ajduk M, Pavić L, Bulimbasić S, Sarlija M, Pavić P, Patrlj L, Brkljacić B. Multidetector-row computed 
tomography in evaluation of atherosclerotic carotid plaques complicated with intraplaque hemorrhage. Ann 
Vasc Surg. 2009 Mar;23(2):186-93. 
 
76) Ajduk M, Bulimbasić S, Pavić L, Sarlija M, Patrlj L, Brkljacić B, Pavić P, Cikara I, Ivanac G. 
Comparison of multidetector-row computed tomography and duplex Doppler ultrasonography in detecting 
atherosclerotic carotid plaques complicated with intraplaque hemorrhage. Coll Antropol. 2013 
Mar;37(1):213-9 
 
77) Kume S, Hama S, Yamane K, Wada S, Nishida T, Kurisu K. Vulnerable carotid arterial plaque causing 
repeated ischemic stroke can be detected with B-mode ultrasonography as a mobile component: Jellyfish 
sign. Neurosurg Rev. 2010 Oct;33(4):419-30 
 
78) Cury RC, Houser SL, Furie KL, Stone JR, Ogilvy CS, Sherwood JB, Muller JE, Brady TJ, Hinton DP. 
Vulnerable plaque detection by 3.0 tesla magnetic resonance  imaging. Invest Radiol. 2006 Feb;41(2):112-5. 
 
79) Wahlgren CM, Zheng W, Shaalan W, Tang J, Bassiouny HS. Human carotid plaque calcification and 
vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression 
and symptomatology. Cerebrovasc Dis. 2009;27(2):193-200. 
 
80) Underhill HR, Yuan C, Yarnykh VL, Chu B, Oikawa M, Polissar NL, Schwartz SM, Jarvik GP, 
Hatsukami TS. Arterial remodeling in [corrected] subclinical carotid artery disease. JACC Cardiovasc 
Imaging. 2009 Dec; 2(12):1381-9. 
 
81) Demarco JK, Ota H, Underhill HR, Zhu DC, Reeves MJ, Potchen MJ, Majid A, Collar A, Talsma JA, 
Potru S, Oikawa M, Dong L, Zhao X, Yarnykh VL, Yuan C. MR carotid plaque imaging and contrast-
enhanced MR angiography identifies lesions  associated with recent ipsilateral thromboembolic symptoms: 
an in vivo study at 3T. AJNR Am J Neuroradiol. 2010 Sep;31(8):1395-402. 
 
82) Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in 
human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 
2000 Aug 29;102(9):959-64. 
 
83) Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B, Takaya N, Polissar NL, Yuan C. In 
vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid 
plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. 
Circulation. 2005 Nov 29;112(22):3437-44. 
 
84) Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, Ellington E, Ferguson MS, Hatsukami 
TS. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent 
transient ischemic attack or stroke. Circulation. 2002 Jan 15;105(2):181-5. 
 
85) Saba L, Potters F, van der Lugt A, Mallarini G. Imaging of the fibrous cap in  atherosclerotic carotid 
plaque. Cardiovasc Intervent Radiol. 2010 Aug;33(4):681-9. doi: 10.1007/s00270-010-9828-8.  
 
  38 
86) Saba L, Mallarini G. Fissured fibrous cap of vulnerable carotid plaques and symptomaticity: are they 
correlated? Preliminary results by using multi-detector-row CT angiography. Cerebrovasc Dis. 
2009;27(4):322-7.  
 
87) Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. 
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque 
hemorrhage. Arterioscler Thromb Vasc Biol. 2005; 25: 2054–2061. 
 
88) McCarthy MJ, Loftus IM, Thompson MM, Jones L, London NJ, Bell PR, Naylor AR, Brindle NP. 
Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque 
morphology. J Vasc Surg. 1999; 30: 261–268. 
 
89) Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS. MR imaging of adventitial vasa vasorum in 
carotid atherosclerosis. Magn Reson Med. 2008; 59: 507–514. 
 
90) Wasserman BA. Advanced contrast-enhanced MRI for looking beyond the lumen to predict stroke: 
building a risk profile for carotid plaque. Stroke. 2010 Oct;41(10 Suppl):S12-6. 
 
91) Romero JM, Babiarz LS, Forero NP, Murphy EK, Schaefer PW, Gonzalez RG, Lev MH. Arterial wall 
enhancement overlying carotid plaque on CT angiography correlates with symptoms in patients with high 
grade stenosis. Stroke. 2009; 40: 1894–1896. 
 
92) Romero JM, Pizzolato R, Atkinson W, Meader A, Jaimes C, Lamuraglia G, Jaff MR, Buonanno F, 
Delgado Almandoz J, Gonzalez RG. Vasa vasorum enhancement on computerized tomographic angiography 
correlates with symptomatic patients with 50% to 70% carotid artery stenosis. Stroke. 2013 
Dec;44(12):3344-9. 
 
93) Millon A, Boussel L, Brevet M, Mathevet JL, Canet-Soulas E, Mory C, Scoazec JY, Douek P. Clinical 
and histological significance of gadolinium enhancement in  carotid atherosclerotic plaque. Stroke. 2012 
Nov;43(11):3023-8. 
 
94)  Millon A, Boussel L, Brevet M, Mathevet JL, Canet-Soulas E, Mory C, Scoazec JY, Douek P. Clinical 
and histological significance of gadolinium enhancement in carotid atherosclerotic plaque. Stroke. 2012 
Nov;43(11):3023-8. 
 
95) Hoogi A, Zurakhov G, Adam D. Evaluation of a 3D technique for quantifying neovascularization within 
plaques imaged by contrast enhanced ultrasound. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:1124-7.  
 
96) van den Oord SC, Akkus Z, Roeters van Lennep JE, Bosch JG, van der Steen AF, Sijbrands EJ, Schinkel 
AF. Assessment of subclinical atherosclerosis and intraplaque neovascularization using quantitative contrast-
enhanced ultrasound in patients with familial hypercholesterolemia. Atherosclerosis. 2013 Nov;231(1):107-
13.  
 
97) Akkus Z, Hoogi A, Renaud G, van den Oord SC, Ten Kate GL, Schinkel AF, Adam D, de Jong N, van 
der Steen AF, Bosch JG. New quantification methods for carotid intra-plaque neovascularization using 
contrast-enhanced ultrasound. Ultrasound Med Biol. 2014 Jan;40(1):25-36.  
 
98) van den Oord SC, van der Burg J, Akkus Z, Bosch JG, van Domburg RT, Sijbrands  EJ, van der Steen 
AF, Schinkel AF. Impact of gender on the density of intraplaque neovascularization: A quantitative contrast-
enhanced ultrasound study. Atherosclerosis. 2014 Apr;233(2):461-6 
 
99) Jaipersad AS, Shantsila A, Silverman S, Lip GY, Shantsila E. Evaluation of carotid plaque 
neovascularization using contrast ultrasound. Angiology. 2013 Aug;64(6):447-50. 
 
  39 
100) Truijman MT, Kwee RM, van Hoof RH, Hermeling E, van Oostenbrugge RJ, Mess WH,  Backes WH, 
Daemen MJ, Bucerius J, Wildberger JE, Kooi ME. Combined 18F-FDG PET-CT and DCE-MRI to assess 
inflammation and microvascularization in atherosclerotic plaques. Stroke. 2013 Dec;44(12):3568-70.  
 
101) Calcagno C, Ramachandran S, Izquierdo-Garcia D, Mani V, Millon A, Rosenbaum D, Tawakol A, 
Woodward M, Bucerius J, Moshier E, Godbold J, Kallend D, Farkouh ME, Fuster V, Rudd JH, Fayad ZA. 
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for 
imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1884-93.  
 
102) Schroeder AP, Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis. 1995 Dec;118 
Suppl:S141-9. 
 
103) de Boer OJ, van der Wal AC, Teeling P, Becker AE. Leucocyte recruitment in rupture prone regions of 
lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res. 1999 Feb;41(2):443-9. 
  
104) van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of 
thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the 
dominant plaque morphology. Circulation. 1994 Jan;89(1):36-44. 
 
105) Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, Biedermann BC. Arterial 
neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic 
atherosclerosis. Circulation. 2004 Nov 2;110(18):2843-50. 
 
106) Moulton KS, Vakili K, Zurakowski D Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, 
Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and 
progression of advanced atherosclerosis. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4736-41. 
 
107) Lennartz MR, Aggarwal A, Michaud TM, Feustel PJ, Jones DM, Brosnan MJ, Keller  RS, Loegering 
DJ, Kreienberg PB. Ligation of macrophage Fcγ receptors recapitulates the gene expression pattern of 
vulnerable human carotid plaques. PLoS One. 2011;6(7):e21803. 
 
108) Ruehm SG, Corot C, Vogt P, Cristina H, Debatin JF. Ultrasmall superparamagnetic iron oxide-
enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits. Acad Radiol. 2002 May; 9 Suppl 
1:S143-4. 
 
109) Trivedi RA, Mallawarachi C, U-King-Im JM, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, 
Kirkpatrick PJ, Brown J, Gillard JH. Identifying inflamed carotid plaques using in vivo USPIO-enhanced 
MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1601-6. 
 
110) Annovazzi A, Bonanno E, Arca M, D'Alessandria C, Marcoccia A, Spagnoli LG, Violi F, Scopinaro F, 
De Toma G, Signore A. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable 
atherosclerotic plaques. Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):117-26. 
 
111) Tang TY, Howarth SP, Miller SR, Graves MJ, U-King-Im JM, Li ZY, Walsh SR, Patterson AJ, 
Kirkpatrick PJ, Warburton EA, Varty K, Gaunt ME, Gillard JH. Correlation of carotid atheromatous plaque 
inflammation using USPIO-enhanced MR  imaging with degree of luminal stenosis. Stroke. 2008 
Jul;39(7):2144-7.  
 
112) Howarth SP, Tang TY, Trivedi R, Weerakkody R, U-King-Im J, Gaunt ME, Boyle JR, Li ZY, Miller 
SR, Graves MJ, Gillard JH. Utility of USPIO-enhanced MR imaging to  identify inflammation and the 
fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol. 2009 Jun;70(3):555-
60. 
 
113) Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, 
Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. In vivo 18F-fluorodeoxyglucose positron 
  40 
emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J 
Am Coll Cardiol 2006; 48 (9): 1818-24. 
 
114)  Graebe M, Pedersen SF, Borgwardt L, Højgaard L, Sillesen H, Kjaer A. Molecular pathology in 
vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-
PET). Eur J Vasc Endovasc Surg. 2009 Jun;37(6):714-21.  
 
115) Graebe M, Pedersen SF, Højgaard L, Kjaer A, Sillesen H. 18FDG PET and ultrasound echolucency in 
carotid artery plaques. JACC Cardiovasc Imaging. 2010 Mar;3(3):289-95. doi: 10.1016/j.jcmg.2010.01.001. 
PubMed PMID: 20223427. 
 
116) Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi 
M, Amano T, Matsubara T, Murohara T. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 
fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed 
tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for 
percutaneous coronary intervention. Clin Ther 2010; 32 (14): 2337-47. 
 
117) Fukuda K, Iihara K, Maruyama D, Yamada N, Ishibashi-Ueda H. Relationship between Carotid Artery 
Remodeling and Plaque Vulnerability with T1-Weighted Magnetic Resonance Imaging. J Stroke 
Cerebrovasc Dis. 2014 Feb 27. pii: S1052-3057(13)00525-9. 
 
118) Achenbach S, Ropers D, Hoffmann U, MacNeill B, Baum U, Pohle K, Brady TJ, Pomerantsev E, 
Ludwig J, Flachskampf FA, Wicky S, Jang IK, Daniel WG. Assessment  of coronary remodeling in stenotic 
and nonstenotic coronary atheroscleroticlesions by multidetector spiral computed tomography. J Am Coll 
Cardiol. 2004 Mar  3;43(5):842-7.  
 
119) Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: a type of 
vulnerable plaque. J Interv Cardiol. 2003 Jun; 16(3):267-72 
 
120) Hardie AD, Kramer CM, Raghavan P, Baskurt E, Nandalur KR. The impact of expansive arterial 
remodeling on clinical presentation in carotid artery disease: a multidetector CT angiography study. AJNR 
Am J Neuroradiol. 2007 Jun-Jul;28(6):1067-70. 
 
121) Ohara T, Toyoda K, Otsubo R, Nagatsuka K, Kubota Y, Yasaka M, Naritomi H, Minematsu K. 
Eccentric stenosis of the carotid artery associated with ipsilateral cerebrovascular events. AJNR Am J 
Neuroradiol. 2008 Jun;29(6):1200-3. 
 
122) Xu D, Hippe DS, Underhill HR, Oikawa-Wakayama M, Dong L, Yamada K, Yuan C, Hatsukami TS. 
Prediction of high-risk plaque development and plaque progression with the carotid atherosclerosis score. 
JACC Cardiovasc Imaging. 2014 Apr;7(4):366-73 
 
123) Adraktas DD, Tong E, Furtado AD, Cheng SC, Wintermark M. Evolution of CT imaging features of 
carotid atherosclerotic plaques in a 1-year prospective cohort study. J Neuroimaging. 2014 Jan-Feb;24(1):1-
6. 
 
124) Ukwatta E, Yuan J, Rajchl M, Qiu W, Tessier D, Fenster A. 3-d carotid multi-region MRI segmentation 
by globally optimal evolution of coupled surfaces. IEEE Trans Med Imaging. 2013 Apr;32(4):770-85. 
 
125) Saba L, Sanfilippo R, Sannia S, Anzidei M, Montisci R, Mallarini G, Suri JS. Association Between 
Carotid Artery Plaque Volume, Composition, and Ulceration: A Retrospective Assessment With MDCT. 
AJR Am J Roentgenol. 2012;199:151-6. 
 
126) Saba L, Anzidei M, Marincola BC, Piga M, Raz E, Bassareo PP, Napoli A, Mannelli L, Catalano C, 
Wintermark M. Imaging of the Carotid Artery Vulnerable Plaque. Cardiovasc Intervent Radiol. 2013 Aug 3. 
[Epub ahead of print] PubMed PMID: 23912494.  
 
  41 
127) Bluth EI. Value of US in selecting patients for carotid angioplasty and stent  placement. Radiology. 
2005 Oct;237(1):374-5; author reply 375.  
 
128) Chiu B, Shamdasani V, Entrekin R, Yuan C, Kerwin WS. Characterization of carotid plaques on 3-
dimensional ultrasound imaging by registration with multicontrast magnetic resonance imaging. J Ultrasound 
Med. 2012 Oct;31(10):1567-80.  
 
129) Gaitini D, Soudack M. Diagnosing carotid stenosis by Doppler sonography: state of the art. J 
Ultrasound Med. 2005 Aug;24(8):1127-36.  
 
130) Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, Carroll BA, Eliasziw M, 
Gocke J, Hertzberg BS, Katarick S, Needleman L, Pellerito J, Polak JF, Rholl KS, Wooster DL, Zierler E; 
Society of Radiologists in Ultrasound. Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis--
Society of Radiologists in Ultrasound consensus conference. Ultrasound Q. 2003 Dec;19(4):190-8.  
 
131) O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and 
media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health 
Study Collaborative  Research Group. N Engl J Med. 1999 Jan 7;340(1):14-22. 
 
132)  Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-
media thickness and cardiovascular events. N Engl J Med. 2011 Jul 21;365(3):213-21.  
 
133) Brennen DJ, Hall EJ. Computed Tomography - An increasing source of Radiation Exposure. NEJM 
2007;357:2277-2284. 
 
134) Nickoloff E, Alderson P. Radiation exposure to patients from CT: reality public perception, and policy. 
AJR Am J Roentgenol  2001;177:285-287 
 
135) Ertl-Wagner BB, Hoffmann RT, Bruning R, Herrmann K, Snyder B, Blume JD, Reiser MF. (2004) 
Multi-detector row CT angiography of the brain at various Kilovoltage settings. Radiology 231:528-535 
 
136) Cashaman JD, McCredie J, Henry DA. (1991)  Intravenous contrast media: use and associated 
mortality. Med J Aust 155:618-623 
 
137) Morcos SK. (2005) Acute serious and fatal reactions to contrast media: our current understanding. Br J 
Radiol 78:686-693 
 
138) Rudnick MR, Kesselheim A, Goldfarb S. Contrast-induced nephropathy: how it develops, how to 
prevent it. Cleve Clin J Med 2006; 73: 75-80, 83-7. 
 
139) Chappell  FM,  Wardlaw  JM,  Young  GR,  et  al.  Carotid  artery  stenosis: accuracy of noninvasive 
tests–individual patient data meta-analysis. Radiology. 2009; 251:493–502. 
 
140) J Sanz, ZA Fayad. Imaging of atherosclerotic cardiovascular disease, Nature 2008;451: 953–957 
 
141) Demos SM, Alkan-Onyuksel H, Kane BJ, Ramani K, Nagaraj A, Greene R, Klegerman M, McPherson 
DD. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic 
enhancement, J Am Coll Cardiol, 1999;33: 867–875. 
 
142) Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, 
Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: implications for 
detecting vulnerable plaques, Circulation, 2001;104:1280–1285. 
 
143) Neubauer AM, Sim H, Winter PM, Caruthers SD, Williams TA, Robertson JD, Sept D, Lanza GM, 
Wickline SA. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging, Magn 
Reson Med, 2008;60:1353–1361. 
  42 
 
144) Li H, Gray BD, Corbin I, Lebherz C, Choi H, Lund-Katz S, Wilson JM, Glickson JD, Zhou R. MR and 
fluorescent imaging of low-density lipoprotein receptors, Acad Radiol, 2004;11:1251–1259. 
 
145) Hayek SS, Sharma R, Kwon S, Sharma A, Chen CJ. Temperature and magnetic resonance 
characteristics of zinc, manganese, gadolinium, gold, iron magnetic nanoparticles and cytokine synergy in 
hyperthermia, J Biomed Sci Eng 2008;1:147–209. 
 
146) Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, 
Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005,307:538–544. 
 
147) Winter PM, Cai K, Chen J, Adair CR, Kiefer GE, Athey PS, Gaffney PJ, Buff CE, Robertson JD, 
Caruthers SD, Wickline SA, Lanza GM. Targeted PARACEST nanoparticle contrast agent for the detection 
of fibrin, Magn Reson Med 2006;56: 1384–1388. 
 
148) Freilinger TM, Schindler A, Schmidt C, Grimm J, Cyran C, Schwarz F, Bamberg F, Linn J, Reiser M, 
Yuan C, Nikolaou K, Dichgans M, Saam T. Prevalence of nonstenosing, complicated atherosclerotic plaques 
in cryptogenic stroke. JACC Cardiovasc Imaging. 2012;5(4):397-405. Epub 2012/04/14. doi: 
10.1016/j.jcmg.2012.01.012. PubMed PMID: 22498329. 
 
149) Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, 
Michel JB, Corot C, Ballet S. Molecular and cellular targets  of the MRI contrast agent P947 for 
atherosclerosis imaging. Mol Pharm. 2012 Apr 2;9(4):850-61.  
 
150) Chan JM, Monaco C, Wylezinska-Arridge M, Tremoleda JL, Gibbs RG. Imaging of the vulnerable 
carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI. 
Eur J Vasc Endovasc Surg. 2014 May;47(5):462-9.  
 
151) Moody AR, Murphy RE, Morgan PS, Martel AL, Delay GS, Allder S, MacSweeney ST,  Tennant WG, 
Gladman J, Lowe J, Hunt BJ. Characterization of complicated carotid plaque with magnetic resonance direct 
thrombus imaging in patients with cerebral  ischemia. Circulation. 2003 Jun 24;107(24):3047-52 
 
152) Wasserman BA, Astor B, Sharrett AR, Swingen C, Catellier D.  MRI Measurements of Carotid 
Plaque in the Atherosclerosis Risk in Communities (ARIC) Study: Methods, Reliability and 
Descriptive Statistics.  J Magn Reson Imaging.  2010;31(2):406-415. 
 
153) Troyer A, Saloner D, Pan XM, Velez P, Rapp JH; Assessment of Carotid Stenosis  by Comparison with 
Endarterectomy Plaque Trial Investigators. Major carotid plaque surface irregularities correlate with 
neurologic symptoms. J Vasc Surg. 2002 Apr;35(4):741-7. 
 
154) Polak JF, O'Leary DH, Kronmal RA, Wolfson SK, Bond MG, Tracy RP, Gardin JM, Kittner SJ, Price 
TR, Savage PJ. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease 
severity to stroke and transient ischemic attack. Radiology. 1993 Aug;188(2):363-70. 
 
155) Anderson GB, Ashforth R, Steinke DE, Ferdinandy R, Findlay JM. CT angiography for the detection 
and characterization of carotid artery bifurcation disease. Stroke. 2000 Sep;31(9):2168-74. 
 
156) Sangiorgi G, Bedogni F, Sganzerla P, Binetti G, Inglese L, Musialek P, Esposito G, Cremonesi A, Biasi 
G, Jakala J, Mauriello A, Biondi-Zoccai G. The Virtual histology In CaroTids Observational RegistrY 
(VICTORY) study: a European  prospective registry to assess the feasibility and safety of intravascular 
ultrasound and virtual histology during carotid interventions. Int J Cardiol. 2013 Oct 3;168(3):2089-93 
 
157) Hitchner E, Zayed MA, Lee G, Morrison D, Lane B, Zhou W. Intravascular ultrasound as a clinical 
adjunct for carotid plaque characterization. J Vasc Surg. 2014 Mar;59(3):774-80 
 
  43 
158) Dembo T, Tanahashi N. Recurring extracranial internal carotid artery vasospasm detected by 
intravascular ultrasound. Intern Med. 2012;51(10):1249-53. 
 
159) Qiao Y, Etesami M, Astor BC, Zeiler SR, Trout HH 3rd, Wasserman BA. Carotid plaque 
neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular 
ischemic events. AJNR Am J Neuroradiol. 2012 Apr;33(4):755-60. 
160) Miura T, Matsukawa N, Sakurai K, Katano H, Ueki Y, Okita K, Yamada K, Ojika K. Plaque 
vulnerability in internal carotid arteries with positive remodeling. Cerebrovasc Dis Extra. 2011 Jan-
Dec;1(1):54-65. 
 
161) Vukadinovic D, Rozie S, van Gils M, van Walsum T, Manniesing R, van der Lugt A, Niessen WJ. 
Automated versus manual segmentation of atherosclerotic carotid plaque volume and components in CTA: 
associations with cardiovascular risk factors. Int J Cardiovasc Imaging. 2012 Apr;28(4):877-87. 
 
162) Rozie S, de Weert TT, de Monyé C, Homburg PJ, Tanghe HL, Dippel DW, van der Lugt A. 
Atherosclerotic plaque volume and composition in symptomatic carotid arteries assessed with multidetector 
CT angiography; relationship with severity of stenosis and cardiovascular risk factors. Eur Radiol. 2009 
Sep;19(9):2294-301. doi: 10.1007/s00330-009-1394-6. 
 
163 Wannarong T, Parraga G, Buchanan D, Fenster A, House AA, Hackam DG, Spence JD. Progression of 
carotid plaque volume predicts cardiovascular events. Stroke. 2013 Jul;44(7):1859-65. 
 
164) Heliopoulos J, Vadikolias K, Piperidou C, Mitsias P. Detection of carotid artery plaque ulceration using 
3-dimensional ultrasound. J Neuroimaging. 2011 Apr;21(2):126-31. 
 
165) Madani A, Beletsky V, Tamayo A, Munoz C, Spence JD. High-risk asymptomatic carotid stenosis: 
ulceration on 3D ultrasound vs TCD microemboli. Neurology. 2011 Aug 23;77(8):744-50. 
 
166) Wasserman BA, Astor BC, Sharrett AR, Swingen C, Catellier D. MRI measurements  of carotid plaque 
in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J 
Magn Reson Imaging. 2010 Feb;31(2):406-15 
 
167) van Dijk AC, Truijman MT, Hussain B, Zadi T, Saiedie G, de Rotte AA, Liem MI,  van der Steen AF, 
Daemen MJ, Koudstaal PJ, Nederkoorn PJ, Hendrikse J, Kooi ME, van der Lugt A. Intraplaque Hemorrhage 
and the Plaque Surface in Carotid Atherosclerosis: The Plaque At RISK Study (PARISK). AJNR Am J 
Neuroradiol. 2015 Nov;36(11):2127-33 
 
168) Zhao XQ, Hatsukami TS, Hippe DS, Sun J, Balu N, Isquith DA, Crouse JR 3rd, Anderson T, Huston J 
3rd, Polissar N, O'Brien K, Yuan C; AIM-HIGH Carotid MRI Sub-study Investigators. Clinical factors 
associated with high-risk carotid plaque features as assessed by magnetic resonance imaging in patients with 
established vascular disease (from the AIM-HIGH Study). Am J Cardiol. 2014 Nov 1;114(9):1412-9. 
 
169) Saam T, Hetterich H, Hoffmann V, Yuan C, Dichgans M, Poppert H, Koeppel T, Hoffmann U, Reiser 
MF, Bamberg F. Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage 
on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol. 2013;62:1081-1091 
 
170) Gupta A, Baradaran H, Schweitzer AD, Kamel H, Pandya A, Delgado D, Dunning A, Mushlin AI, 
Sanelli PC. Carotid plaque mri and stroke risk: A systematic review and meta-analysis. Stroke. 
2013;44:3071-3077 
 
171) Hosseini AA, Kandiyil N, Macsweeney ST, Altaf N, Auer DP. Carotid plaque hemorrhage on mri 
strongly predicts recurrent ischemia and stroke. Ann Neurol. 2013;73:774-84 
 
172) Takaya N, Cai J, Ferguson MS, Yarnykh VL, Chu B, Saam T, Polissar NL, Sherwood J, Cury RC, 
Anders RJ, Broschat KO, Hinton D, Furie KL, Hatsukami TS, Yuan C. Intra- and interreader reproducibility 
  44 
of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium 
contrast enhancement. J Magn Reson Imaging. 2006;24:203-210 
 
173) Wang J, Yarnykh VL, Hatsukami T, Chu B, Balu N, Yuan C. Improved suppression of plaque-
mimicking artifacts in black-blood carotid atherosclerosis imaging using a multislice motion-sensitized 
driven-equilibrium (msde) turbo spin-echo (tse) sequence. Magn Reson Med. 2007;58:973-981 
 
174) Fan Z, Zhang Z, Chung YC, Weale P, Zuehlsdorff S, Carr J, Li D. Carotid arterial wall mri at 3t using 
3d variable-flip-angle turbo spin-echo (tse) with flow-sensitive dephasing (fsd). J Magn Reson Imaging. 
2010;31:645-654 
 
175) Yarnykh VL, Yuan C. T1-insensitive flow suppression using quadruple inversion-recovery. Magn 
Reson Med. 2002;48:899-905 
 
176 Ota H, Yarnykh VL, Ferguson MS, Underhill HR, Demarco JK, Zhu DC, Oikawa M, Dong L, Zhao X, 
Collar A, Hatsukami TS, Yuan C. Carotid intraplaque hemorrhage imaging at 3.0-t mr imaging: Comparison 
of the diagnostic performance of three t1-weighted sequences. Radiology. 2010;254:551-563 
 
177) Trivedi RA, U-King-Im JM, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, Gillard JH. Mri-
derived measurements of fibrous-cap and lipid-core thickness: The potential for identifying vulnerable 
carotid plaques in vivo. NEURORADIOLOGY. 2004;46:738-743 
 
178) Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, 
fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 
1996;94:932-938 
 
179) Wang J, Bornert P, Zhao H, Hippe DS, Zhao X, Balu N, Ferguson MS, Hatsukami TS, Xu J, Yuan C, 
Kerwin WS. Simultaneous noncontrast angiography and intraplaque hemorrhage (snap) imaging for carotid 
atherosclerotic disease evaluation. Magn Reson Med. 2012;69:337-345 
 
180) Zhu DC, Vu AT, Ota H, DeMarco JK. An optimized 3d spoiled gradient recalled echo pulse sequence 
for hemorrhage assessment using inversion recovery and multiple echoes (3d shine) for carotid plaque 
imaging. Magn Reson Med. 2010;64:1341-1351 
 
181) Dai Y, Lv P, Lin J, Luo R, Liu H, Ji A, Liu H, Fu C.Comparison study between multicontrast 
atherosclerosis characterization (MATCH) and conventional multicontrast MRI of carotid plaque 
with histology validation. J Magn Reson Imaging. 2017 Mar;45(3):764-770. 
 
182) Fan Z, Yu W, Xie Y, Dong L, Yang L, Wang Z, Conte AH, Bi X, An J, Zhang T, Laub G, Shah PK, 
Zhang Z, Li D. Multi-contrast atherosclerosis characterization (match) of carotid plaque with a single 5-min 
scan: Technical development and clinical feasibility. J Cardiovasc Magn Reson. 2014;16:53 
 
183) Balu N, Yarnykh VL, Chu B, Wang J, Hatsukami T, Yuan C. Carotid plaque assessment using fast 3d 
isotropic resolution black-blood mri. Magn Reson Med. 2010;65:627-637 
 
184) Li L, Chai JT, Biasiolli L, Robson MD, Choudhury RP, Handa AI, Near J, Jezzard P. Black-blood 
multicontrast imaging of carotid arteries with dante-prepared 2d and 3d mr imaging. Radiology. 
2014;273:560-569 
 
185) Saba L, Mallarin G. Window settings for the study of calcified carotid plaques with multidetector CT 
angiography. AJNR Am J Neuroradiol. 2009 Aug;30(7):1445-50 
 
186) Saba L, Mallarini G. Carotid plaque enhancement and symptom correlations: an evaluation by using 
multidetector row CT angiography. AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):1919-25 
 
  45 
187) Saam T, Kerwin WS, Chu B, Cai J, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek 
B, Yarnykh VL, Flemming K, Huston J 3rd, Insull W Jr, Morrisett JD, Rand SD, DeMarco KJ, Yuan C. 
Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment 
of carotid atherosclerosis. J Cardiovasc Magn Reson. 2005;7(5):799-808 
 
188) Saam T, Raya JG, Cyran CC, Bochmann K, Meimarakis G, Dietrich O, Clevert DA, Frey U, Yuan C, 
Hatsukami TS, Werf A, Reiser MF, Nikolaou K. High resolution carotid black-blood 3T MR with parallel 
imaging and dedicated 4-channel surface coils. J Cardiovasc Magn Reson. 2009 Oct 27;11:41. 
 
189) Bar M, Roubec M, Farana R, Ličev L, Tomášková H, Školoudík D. Inter-rater reliability of carotid 
atherosclerotic plaque quantification by 3-dimensional sonography. J Ultrasound Med. 2014 Jul;33(7):1273-
8 
 
190) Hartmann A, Mohr JP, Thompson JL, Ramos O, Mast H. Interrater reliability of plaque morphology 
classification in patients with severe carotid artery stenosis. Acta Neurol Scand. 1999 Jan;99(1):61-4. 
 
191) Sun J, Canton G, Balu N, Hippe DS, Xu D, Liu J, Hatsukami TS, Yuan C. Blood Pressure Is a Major 
Modifiable Risk Factor Implicated in Pathogenesis of Intraplaque Hemorrhage: An In Vivo Magnetic 
Resonance Imaging Study. Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):743-9.  
 
192) Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, Tran N, Polissar NL, Isaac C, Ferguson MS, 
Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS.  Association between carotid plaque 
characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial 
results. Stroke. 2006 Mar;37(3):818-23. 
 
193) Kwee RM, van Oostenbrugge RJ, Mess WH, Prins MH, van der Geest RJ, ter Berg JW, Franke CL, 
Korten AG, Meems BJ, van Engelshoven JM, Wildberger JE, Kooi ME.  MRI of carotid atherosclerosis to 
identify TIA and stroke patients who are at risk of a recurrence. J Magn Reson Imaging. 2013 
May;37(5):1189-94. 
 
194) Gaens ME, Backes WH, Rozel S, Lipperts M, Sanders SN, Jaspers K, Cleutjens JP, Sluimer JC, 
Heeneman S, Daemen MJ, Welten RJ, Daemen JW, Wildberger JE, Kwee RM,  Kooi ME. Dynamic 
contrast-enhanced MR imaging of carotid atherosclerotic plaque:  model selection, reproducibility, and 
validation. Radiology. 2013 Jan;266(1):271-9. 
 
195) Chen H, Sun J, Kerwin WS, Balu N, Neradilek MB, Hippe DS, Isquith D, Xue Y, Yamada K, Peck S, 
Yuan C, O'Brien KD, Zhao XQ.  Scan-rescan reproducibility of quantitative assessment of inflammatory 
carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study.  J 




197) Ooi YC, Gonzalez NR. Management of extracranial carotid artery disease. Cardiol Clin. 2015 
Feb;33(1):1-35. 
 
198) Huibers A, de Borst GJ, Wan S, Kennedy F, Giannopoulos A, Moll FL, Richards T. Non-invasive 
Carotid Artery Imaging to Identify the Vulnerable Plaque: Current Status and Future Goals. Eur J Vasc 
Endovasc Surg. 2015 Nov;50(5):563-72.  
 
199) Varetto G, Gibello L, Castagno C, Quaglino S, Ripepi M, Benintende E, Gattuso A, Garneri P, Zan S, 
Capaldi G, Bertoldo U, Rispoli P. Use of Contrast-Enhanced Ultrasound in Carotid Atherosclerotic Disease: 
Limits and Perspectives. Biomed Res Int. 2015;2015:293163.  
 
200) Funaki T, Iihara K, Miyamoto S, Nagatsuka K, Hishikawa T, Ishibashi-Ueda H. Histologic 
characterization of mobile and nonmobile carotid plaques detected with ultrasound imaging. J Vasc Surg. 
2011 Apr;53(4):977-83. 
  46 
 
201) U-King-Im JM, Fox AJ, Aviv RI, Howard P, Yeung R, Moody AR, Symons SP. Characterization of 
carotid plaque hemorrhage: a CT angiography and MR intraplaque hemorrhage study. Stroke. 2010 
Aug;41(8):1623-9. 
 
202) Trelles M, Eberhardt KM, Buchholz M, Schindler A, Bayer-Karpinska A, Dichgans  M, Reiser MF, 
Nikolaou K, Saam T. CTA for screening of complicated atherosclerotic carotid plaque--American Heart 
Association type VI lesions as defined by MRI. AJNR Am J Neuroradiol. 2013 Dec;34(12):2331-7. 
 
203) Bayer-Karpinska A, Schwarz F, Wollenweber FA, Poppert H, Boeckh-Behrens T, Becker A, Clevert 
DA, Nikolaou K, Opherk C, Dichgans M, Saam T. The carotid plaque imaging in acute stroke (CAPIAS) 
study: protocol and initial baseline data. BMC Neurol. 2013 Dec 13;13:201. 
 
204) Truijman MT, Kooi ME, van Dijk AC, de Rotte AA, van der Kolk AG, Liem MI, Schreuder FH, 
Boersma E, Mess WH, van Oostenbrugge RJ, Koudstaal PJ, Kappelle LJ, Nederkoorn PJ, Nederveen AJ, 
Hendrikse J, van der Steen AF, Daemen MJ, van der Lugt A. Plaque At RISK (PARISK): prospective 
multicenter study to improve diagnosis of high-risk carotid plaques. Int J Stroke. 2014 Aug;9(6):747-54.  
 
205) https://clinicaltrials.gov/ct2/show/NCT02017756  
 
206) Sharma P, Socolow J, Patel S, Pettigrew RI, Oshinski JN. Effect of Gd-DTPA-BMA on blood and 
myocardial T1 at 1.5T and 3T in humans. J Magn Reson Imaging. 2006 Mar;23(3):323-30. 
 
207) Bonati LH, Ederle J, Dobson J, Engelter S, Featherstone RL, Gaines PA, Beard JD, Venables GS, 
Markus HS, Clifton A, Sandercock P, Brown MM; CAVATAS Investigators. Length of carotid stenosis 
predicts peri-procedural stroke or death and restenosis in patients randomized to endovascular treatment or 
endarterectomy. Int J Stroke. 2014 Apr;9(3):297-305. 
 
208) Tardif JC, Spence JD, Heinonen TM, Moody A, Pressacco J, Frayne R, L'allier P, Chow BJ, Friedrich 
M, Black SE, Fenster A, Rutt B, Beanlands R. Atherosclerosis imaging and the Canadian Atherosclerosis 
Imaging Network. Can J Cardiol. 2013 Mar;29(3):297-303. 
 
209) Xie Y, Yu W, Fan Z, et al. High resolution 3D diffusion cardiovascular magnetic resonance of carotid 
vessel wall to detect lipid core without contrast media. Journal of Cardiovascular Magnetic Resonance. 
2014;16(1):67. 
 
210) Fan Z, Zuehlsdorff S, Li D. Prospective Self-Gating for Swallowing Motion: A Feasibility Study in 
Carotid Artery Wall MRI Using 3D Variable-Flip-Angle TSE. Magnetic Resonance in Medicine. 
2012;67(2):490-498 
 
211) Underhill HR, Yuan C. Carotid MRI: a tool for monitoring individual response to cardiovascular 
therapy? Expert Rev. Cardiovasc. Ther. 2011;9:63–80 
 
212) DeMarco JK, Spence JD. Plaque Assessment in the Management of Patients with Asymptomatic 
Carotid Stenosis. Neuroimaging Clin. N. Am. 2016;26:111–127 
 
213) Wintermark M, Rapp JH, Tan J, Saloner D. Unmasking complicated atherosclerotic plaques on carotid 
magnetic resonance angiography: a report of three cases. J Vasc Surg. 2006 Oct;44(4):884-7 
 
214) Eisenmenger LB, Aldred BW, Kim SE, Stoddard GJ, de Havenon A, Treiman GS, Parker DL, McNally 
JS. Prediction of Carotid Intraplaque Hemorrhage Using Adventitial Calcification and Plaque Thickness on 
CTA. AJNR Am J Neuroradiol. 2016 Aug;37(8):1496-503 
 
215) Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of 
lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, 
noninvasive magnetic resonance  imaging. Circulation. 2001 Jul 17;104(3):249-52. 
  47 
 
216) Boussel L, Arora S, Rapp J, Rutt B, Huston J, Parker D, Yuan C, Bassiouny H, Saloner D; MAPP 
Investigators.. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution 
MR imaging--multicenter trial.  Radiology. 2009 Sep;252(3):789-96. 
 
217) Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, Tran N, Polissar NL, Neradilek B, Jarvik GP, 
Isaac C, Garden GA, Maravilla KR, Hashimoto B, Hatsukami  TS. Predictors of carotid atherosclerotic 
plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis. 2007 
Oct;194(2):e34-42 
 
218) Anzidei M, Suri JS, Saba L, Sanfilippo R, Laddeo G, Montisci R, Piga M, Argiolas GM, Raz E. 
Longitudinal assessment of carotid atherosclerosis after Radiation Therapy using Computed Tomography: A 
case control Study. Eur Radiol. 2016 Jan;26(1):72-8. doi: 
 
219) van Gils MJ, Vukadinovic D, van Dijk AC, Dippel DW, Niessen WJ, van der Lugt  A. Carotid 
atherosclerotic plaque progression and change in plaque composition over time: a 5-year follow-up study 
using serial CT angiography. AJNR Am J Neuroradiol. 2012 Aug;33(7):1267-73 
 
220) Fleg JL, Stone GW, Fayad ZA, et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI 
Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012;5:941–955 
 
221) Murata N, Gonzalez-Cuyar LF, Murata K, Fligner C, Dills R, Hippe D, Maravilla KR. Macrocyclic and 
Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone 
Tissue: Preliminary Results From 9 Patients With Normal Renal Function. Invest Radiol. 2016 
Jul;51(7):447-53 
 
222) Stojanov D, Aracki-Trenkic A, Benedeto-Stojanov D. Gadolinium deposition within the dentate nucleus 
and globus pallidus after repeated administrations of  gadolinium-based contrast agents-current status. 
Neuroradiology. 2016  
 
223) Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed 
mechanisms. Biometals. 2016 Jun;29(3):365-76.  
 
224) FDA Drug Safety Communication (2015) FDA evaluating the risk of brain deposits with repeated use 
of gadolinium-based contrast agents for magnetic resonance imaging (MRI). 
http://www.fda.gov/Drugs/DrugSafety/ucm455386.htm 
 
225) Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek MB, Polissar N, 
Monick D, Lee C, Underhill H, Yuan C. MR imaging of carotid plaque  composition during lipid-lowering 
therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging. 2011 Sep;4(9):977-
86. 
 
226) Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE, Barnett HJ. The causes and risk of 
stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid 
Endarterectomy Trial Collaborators. N Engl J Med. 2000 Jun 8;342(23):1693-70. 
 
227) Araki T, Ikeda N, Shukla D, Londhe ND, Shrivastava VK, Banchhor SK, Saba L, Nicolaides A, 
Shafique S, Laird JR, Suri JS. A new method for IVUS-based coronary artery disease risk stratification: A 
link between coronary & carotid ultrasound  plaque burdens. Comput Methods Programs Biomed. 2016 
Feb;124:161-79. 
 
228) Lekadir K, Galimzianova A, Betriu A, Vila MD, Igual L, Rubin D, Fernandez E, Radeva P, Napel S. A 
Convolutional Neural Network for Automatic Characterization  of Plaque Composition in Carotid 
Ultrasound. IEEE J Biomed Health Inform. 2016 Nov 22. [Epub ahead of print] PubMed PMID: 27893402 
 
  48 
229) Lekadir K, Galimzianova A, Betriu A, Del Mar Vila M, Igual L, Rubin DL, Fernandez E, Radeva P, 
Napel S. A Convolutional Neural Network for Automatic Characterization of Plaque Composition in Carotid 
Ultrasound. IEEE J Biomed Health Inform. 2017 Jan;21(1):48-55 
 
230 Chen S, Zhao H, Li J, Zhou Z, Li R, Balu N, Yuan C, Chen H, Zhao X, Evaluation of carotid 
atherosclerotic plaque surface characteristics utilizing simultaneous noncontrast angiography and 
intraplaque hemorrhage (SNAP) technique. J Magn Reson Imaging. 2017 Aug 2. doi: 
10.1002/jmri.25815,  [Epub ahead of print] 
 
231) Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, Isaac C, McDonough J, Natiello 
C, Small R, Ferguson MS, Hatsukami TS. Presence of intraplaque hemorrhage stimulates 
progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. 
Circulation. 2005 May 31;111(21):2768-75. 
 
232) Kwee RM, van Engelshoven JM, Mess WH, ter Berg JW, Schreuder FH, Franke CL, Korten 
AG, Meems BJ, van Oostenbrugge RJ, Wildberger JE, Kooi ME. Reproducibility of fibrous cap 







































  49 
TABLES  
Table 1 
3D Non-contrast Protocol 












Plaque burden and 
distribution 
LRNC 
Sequencea FFE/SPGR IR-TFE/SPGR TSE/FSE TSE/FSE 
Image mode 3D 3D 3D 3D 
Scan plane Axial Coronal Coronal Coronal 
TR, msec 24 15 1000 2500 
TE, msec 4.6 Min 30 250 
FOV, cm 16x16 16x16 16x16 16x16 
Resolution, 
mm2 




1b 0.6 0.6 0.6 
Blood Saturation – 
veins 




Flip angle Flip angle 15; Echo train: variable Echo train: variable 
20 TI=500 ms VFA T1 VFA T2 
  Turbo factor = 30, 
IRTR=800ms 







a Siemens/Philips/GE acronyms.     
 b Interpolated resolution   
 c MSDE: Motion-sensitized driven equilibrium, FSD: Flow sensitized dephasing 
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Table 2 
3D Contrast Protocol 
Name 3D TOF 3D MP-RAGE 
Pre-contrast and post-









Plaque burden and 
distribution, LRNC 
Sequencea FFE/SPGR IR-TFE/SPGR TSE/FSE 
Image mode 3D 3D 3D 
Scan plane Axial Coronal Coronal 
TR, msec 24 15 1000 
TE, msec 4.6 Min 30 
FOV, cm 16x16 16x16 16x16 
Resolution, 
mm2 
0.6x0.6 0.6x0.6 0.6x0.6 
Slice 
thickness, mm 
1b 0.6 0.6 






Flip angle Flip angle 15; Echo train: variable 
20 TI=500 ms VFA T1 









a Siemens/Philips/GE acronyms.     
 b Interpolated resolution   
 c MSDE: Motion-sensitized driven equilibrium, FSD: Flow sensitized dephasing 
*Pulse gating not required for any sequence 
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Table 3 






















Sequencea FFE/SPGR TSE/FSE TSE/FSE TSE/FSE FFE/SPGR 
IR-TFE/IR-
FSPGR 
Image mode 2D 2D 2D 2D 3D 3D 
Scan plane Axial Oblique Axial Axial Axial Axial 
TR, msec 25 2000 800 4800 24 13 
TE, msec 4 8 10 50 Min Min 
FOV, cm 16x12 16x16 16x16 16x16 16x16 16x16 
Resolution, mm2 0.63x0.83 0.63x0.63 0.63x0.63 0.63x0.63 0.63x0.63 0.63x0.63 
Slice thickness, 
mm 
2 2 2 2 2/-1 2/-1 
# of slices 32 6 16 16 40 40 
Blood 
suppressionb 
















factor 30, TI 
500ms, 
IRTR=800ms 
Fat suppression No Yes Yes Yes No 
Water 
excitation 
a Siemens/Philips/GE acronyms.     
 bDIR: Double inversion recovery 
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Table 4 


























Sequencea FFE/SPGR TSE/FSE TSE/FSE FFE/SPGR 
IR-TFE/IR-
FSPGR 
Image mode 2D 2D 2D 3D 3D 
Scan plane Axial Oblique Axial Axial Axial 
TR, msec 25 2000 800 24 13 
TE, msec 4 8 10 Min Min 
FOV, cm 16x12 16x16 16x16 16x16 16x16 
Resolution, mm2 0.63x0.83 0.63x0.63 0.63x0.63 0.63x0.63 0.63x0.63 
Slice thickness, 
mm 
2 2 2 2/-1 2/-1 






















factor 30, TI 
500ms, 
IRTR=800ms 
Fat suppression No Yes Yes No 
Water 
excitation 
a Siemens/Philips/GE acronyms.     
 bMSDE: Motion-sensitized driven equilibrium, QIR: Quadruple inversion recovery 
*Pulse gating not required for any sequence 
**Clinical CE-MRA per institutional protocol can be used before post-contrast 
sequence 
***Double inversion recovery (DIR) can be used but blood suppression may be 
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Mid neck in order 
to cover the 
bifurcation 
From aortic arch to 
mid head 
Scan Mode Scanogram Helical Helical 
Start time NA 
 
Bolus Trackinga 
Range 500 (mm) 8 cm  Variable 
Collimation NA 0.5 x 80 0.5 x 80 
Pitch NA 1 1 
kV 120 120 120 
mA 50-200b 350 350 
Rotation time NA 0.275 second 0.275 second 
Direction  NA 
Caudio – 
Cranialc 
Caudio – Cranialc 
Slice thickness NA 1 mm 1 mm 
Slice interval NA 0.5 mm 0.5 mm 
FOV wide 20 cm 20 cm 
Filter NA Sharp (FL03) Sharp (FL03) 
CTDI(mGy) - 15 15 
DLP(mGy.cm) - 0.6 0.6 
Amount of CM - - 40-50 mLd 
IDR - - 1.4 – 1.5 gI/sec 
Concentration* - - 370 mgI/mL  
Flow rate* - - 4 mL/sec 
 
a – Position of bolus tracking : aortich arch – threshold 100 HU 
b – 50 mA in AP and 200 in Lat 
c – it is possible also cranio-caudal 
d – variable according to the concentration 
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Mid neck in order 
to cover the 
bifurcation 
From aortic arch to 
mid head 
Scan Mode Scanogram Helical Helical 
Start time NA 
 
Bolus Trackinga 
Range 500 (mm) 8 cm  Variable 
Collimation NA 0.6 x 64 0.6 x 64 
Pitch NA 0.55 0.55 
kV 120 120 120 
mA 50-200b 350 350 
Rotation time NA 0.28 second 0.28 second 
Direction  NA Cranio – Caudalc Cranio – Caudalc 
Slice thickness NA 1 mm 1 mm 
Slice interval NA 0.5 mm 0.5 mm 
FOV wide 20 cm 20 cm 
Filter NA Sharp (B30f) Sharp (B30f) 
CTDI(mGy) - 18 18 
DLP(mGy.cm) - 0.65 0.65 
Amount of CM - - 40-50 mLd 
IDR - - 1.4 – 1.5 gI/sec 
Concentration* - - 370 mgI/mL  
Flow rate* - - 4 mL/sec 
 
a – Position of bolus tracking : aortich arch – threshold 100 HU 
b – 50 mA in AP and 200 in Lat 
c – it is possible also caudo-cranial with optimal results 
d – variable according to the concentration 
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Mid neck in order 
to cover the 
bifurcation 
From aortic arch to 
mid head 
Scan Mode Scanogram Helical Helical 
Start time NA 
 
Bolus Trackinga 
Range 500 (mm) 8 cm  Variable 
Collimation NA 0.625 x 128 0.625 x 128 
Pitch NA 0.933 0.933 
kV 120 120 120 
mA 50-200b 350 350 
Rotation time NA 0.5 second 0.5 second 
Direction  NA Cranio – Caudalc Cranio – Caudalc 
Slice thickness NA 1 mm 1 mm 
Slice interval NA 0.5 mm 0.5 mm 
FOV wide 20 cm 20 cm 
Filter NA Sharp (B) Sharp (B) 
CTDI(mGy) - 15 16 
DLP(mGy.cm) - 0.6 0.6 
Amount of CM - - 40-50 mLd 
IDR - - 1.4 – 1.5 gI/sec 
Concentration* - - 370 mgI/mL  
Flow rate* - - 4 mL/sec 
 
a – Position of bolus tracking : aortich arch – threshold 100 HU 
b – 50 mA in AP and 200 in Lat 
c – it is possible also caudo-cranial with optimal results 
d – variable according to the concentration 




















  56 












Mid neck in order 
to cover the 
bifurcation 
From aortic arch to 
mid head 
Scan Mode Scanogram Helical Helical 
Start time NA 
 
Bolus Trackinga 
Range 500 (mm) 8 cm  Variable 
Collimation NA 0.625 x 64 0.625 x 64 
Pitch NA 0.984 0.984 
kV 120 120 120 
mA 50-200b 350 350 
Rotation time NA 0.5 second 0.5 second 
Direction  NA Cranio – Caudalc Cranio – Caudalc 
Slice thickness NA 1 mm 1 mm 
Slice interval NA 0.625 mm 0.625 mm 
FOV wide 20 cm 20 cm 
Filter NA Sharp (B) Sharp (B) 
CTDI(mGy) - 15 16 
DLP(mGy.cm) - 0.6 0.6 
Amount of CM - - 40-50 mLd 
IDR - - 1.4 – 1.5 gI/sec 
Concentration* - - 370 mgI/mL  
Flow rate* - - 4 mL/sec 
 
a – Position of bolus tracking : aortich arch – threshold 100 HU 
b – 50 mA in AP and 200 in Lat 
c – it is possible also caudo-cranial with optimal results 
d – variable according to the concentration 
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FIGURE LEGENDS  
FIGURE 1:  Plaque volume analysis in a 75 year-old man with a TIA. In the Volume Rendered 
image the carotid is traced (a) and in the Curved-Planar-Reconstructed post-processed image (CTA 
module – Aquarius iNtuition Editition ver 4.4.12.138.2907 – TeraRecon, Foster City, CA – USA) 
(b) the plaque is identified based on the green contours (white arrows). The volume analysis with 
automated boundary detection and tissue segmentation is shown in panels c, d and e  (corresponding 
to the three arrows, proximal to distal) with contours delineating the lumen (red contour), outer wall 
(blue contour), and shading of calcium (blue), mixed tissue (green), and lipid component (red).  
 
FIGURE 2: Ulcerated carotid artery plaques detected with CT and MR. In the first case the CTA of 
a 74 year-old man with a TIA demonstrates an ulcerated carotid artery plaque (white arrows) in the 
left internal carotid artery (white arrow) in the MIP (a) and axial source image (b). In the second 
case a MRI analysis of a 63 year-old man with a TIA shows a tiny ulceration (white arrows) in the 
right internal carotid artery is visible in the axial (a) and in the para-coronal plane (b) 
 
FIGURE 3: Carotid atherosclerotic plaque MRI and specimen from a 73 year-old man with stenosis 
of the carotid bulb measuring 69% by NASCET criteria demonstrated on a contrast-enhanced MRA 
(A).  The precontrast (mask) image from the contrast-enhanced MRA demonstrates bright signal 
indicative of intraplaque hemorrhage, specifically subacute blood, or methemaglobin (B, arrow).  
Subacute blood is also identified as bright signal on the precontrast T1W black blood image (C, 
arrow). A rim of hemosiderin is identified as hypointense signal on the post-contrast black blood 
image (D) and a hemosiderin sensitive sequence (E), and confirmed on endarterectomy specimen 
(F, G). The fibrous cap is also delineated (green arrow, D and F). Black blood imaging was 
achieved using 2-dimensional cardiac-gated double inversion recovery turbo spin echo. 
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FIGURE 4: Carotid atherosclerotic plaque MRI and specimen from a 76 year-old woman with 
transient ischemic attacks ipsilateral to carotid bulb stenosis measuring 47% by NASCET criteria 
demonstrated on a contrast-enhanced MRA (A).  Narrowing is caused by the plaque characterized 
by 2-dimensional cardiac-gated double inversion recovery black blood MRI (B). Regional 
enhancement (green arrow) within the lipid core (yellow arrow) suggests focal inflammation with 
neovascularity as confirmed on the endarterectomy specimen (C, green circle).  Contrast-
enhancement is also useful for delineating the fibrous cap (B, C - orange arrowheads). Calcification 
is identified as areas of hypointensity (B, C – red arrows and circle).  
 
FIGURE 5: Smooth left internal carotid artery stenosis with intraplaque hemorrhage. All images 
were acquired with a 16 Channel Neurovascular Coil at 3 T. The contrast-enhaced MRA (CEMRA) 
demonstrates a smooth, non-ulcerated stenosis in the bulbous and post bulbous part of the left 
internal carotid artery (white open arrow)  (a) . Oblique reformat of a coronally acquired 
magnetization prepared rapid gradient echo (MPRAGE) shows extensive intraplaque haemorrhage 
(IPH) which appears hyperintense (white arrow). The IPH is hyperintense on the non-enhanced T1 
FAT SAT spine echo (SE) image (c), and isointense on the gadolinium enhanced T1 FAT SAT SE 
image (d). On the  TOF MRA source data the  IPH appears also hyperintense  but to a lesser degree 
than the intraluminal flow signal (e). 
 
FIGURE 6: Matched cross-sectional images of a carotid plaque with high signal intensity (white 
arrows) consistent with the presence of intraplaque hemorrhage on MP-RAGE (a) and SNAP MRI 
(b). Note the greater conspicuity of the carotid lumen (L) on SNAP compared to the MPRAGE 
image. There is a penetrating ulcer (indicated by the asterisk) that is more easily detected on SNAP 
compared to the TOF MRA image (c).  
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FIGURE 7: In a 68-year-old male patient, co-existent plaque components, fresh intraplaque 
hemorrhage (arrows) and superficila calcifications (arrowheads), are detected by MATCH (first 
row) and the conventional multi-contrast protocol (second row). Compared to T1W TSE and TOF, 
MATCH provides more conspicuous depiction of intraplque hemorrhage on the hyper T1W image 
and calcification on the gray blood image. Notice that the calcification is also visible on the 
MATCH T2W image but not on the T2W TSE image.  
 
FIGURE 8)  Contrast Enhanced MRA of the extracranial carotid bifurcation indicating the level of 
2D FSE images obtained with 1.5 T.  b) T1-weighted double inversion recovery black blood FSE 
image showing an eccentric plaque (arrow) in the internal carotid artery, and c) T2-weighted  
double inversion recovery black blood FSE image at the same level showing a crescentic, 
hypointense signal from the necrotic core which is seprated by higher intensity fibrous cap from the 
flow lumen. 
 
FIGURE 9: Ktrans map of a patient with carotid plaque. Maps were generated using pharmacokinetic 
modeling of dynamic contrast-enhanced MR images. The parametric map is overlaid on anatomic 
MR image, and voxel Ktrans values (Patlak model) are color coded. The necrotic core exhibits low 
Ktrans values at the center of plaque, while the highly vascularized adventitia at the outer rim 
exhibits high Ktrans values. There is another region of higher Ktrans values near the inner rim of the 
plaque. 
 
FIGURE 10: 18F-fluorocholine positron emission tomography-computed tomography (18F-FCH 
PET-CT) image of a symptomatic (arrow) and contralateral asymptomatic (arrow head) carotid 
plaque of a patient who experienced right-sided stroke. A, Diagnostic contrast-enhanced CT shows 
a significant stenosis in the right internal carotid artery because of a calcified plaque, whereas a 
non-calcified atherosclerotic plaque can be seen on the contralateral internal carotid artery. B, CT, 
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inset on the symptomatic plaque. D, CT, inset on the asymptomatic plaque. D, The fused PET-CT 
image denotes a focal area of high 18F-FCH uptake in the right symptomatic carotid plaque, whereas 
there is no visible 18F-FCH uptake in the left asymptomatic carotid plaque. E, fused PET-CT, inset 
on the symptomatic plaque. F, fused PET-CT, inset on the asymptomatic plaque.  
 
 
 
